activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	2595787	CHEMBL1019784	Binding affinity to RPS6KA6 kinase domain.2- C-terminal	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	1200.0	CHEMBL4924	Homo sapiens	Kd	nM	1200.0
	2595787	CHEMBL1019784	Binding affinity to RPS6KA6 kinase domain.2- C-terminal	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	1200.0	CHEMBL4924	Homo sapiens	Kd	nM	1200.0
	2891244	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891245	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891246	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891247	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891248	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891249	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891250	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	4600.0	CHEMBL4924	Homo sapiens	Kd	nM	4600.0
	2891251	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891252	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891253	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891254	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891255	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891256	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891257	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891258	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891259	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891260	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891261	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891262	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891263	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891264	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891265	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2300.0	CHEMBL4924	Homo sapiens	Kd	nM	2300.0
	2891266	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891267	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891268	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891269	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1500.0	CHEMBL4924	Homo sapiens	Kd	nM	1500.0
	2891270	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891271	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891272	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891273	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891274	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891275	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891276	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	18.0	CHEMBL4924	Homo sapiens	Kd	nM	18.0
	2891277	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3100.0	CHEMBL4924	Homo sapiens	Kd	nM	3100.0
	2891278	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2400.0	CHEMBL4924	Homo sapiens	Kd	nM	2400.0
	2891279	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891280	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891281	CHEMBL1039275	Binding constant for RPS6KA6(Kin.Dom.1 - C-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891282	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891283	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891284	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	4600.0	CHEMBL4924	Homo sapiens	Kd	nM	4600.0
	2891285	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891286	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891287	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891288	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891289	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891290	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891291	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	1200.0	CHEMBL4924	Homo sapiens	Kd	nM	1200.0
	2891292	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891293	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891294	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891295	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891296	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	800.0	CHEMBL4924	Homo sapiens	Kd	nM	800.0
	2891297	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891298	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891299	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891300	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891301	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891302	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891303	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891304	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891305	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891306	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891307	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891308	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891309	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891310	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Kd	nM	270.0	CHEMBL4924	Homo sapiens	Kd	nM	270.0
	2891311	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	250.0	CHEMBL4924	Homo sapiens	Kd	nM	250.0
	2891312	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891313	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7500.0	CHEMBL4924	Homo sapiens	Kd	nM	7500.0
	2891314	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3300.0	CHEMBL4924	Homo sapiens	Kd	nM	3300.0
	2891315	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891316	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891317	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891318	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	2891319	CHEMBL1061926	Binding constant for RPS6KA6(Kin.Dom.2 - N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	240.0	CHEMBL4924	Homo sapiens	Kd	nM	240.0
	2921993	CHEMBL1052961	Inhibition of RPS6KA6 kinase domain 1 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	92.0	CHEMBL4924	Homo sapiens	Activity	%	92.0
	2921994	CHEMBL1052962	Inhibition of RPS6KA6 kinase domain 2 assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	86.0	CHEMBL4924	Homo sapiens	Activity	%	86.0
	2928496	CHEMBL1043888	Binding affinity to RSK4 kinase domain 2 C-terminal assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	5.8	CHEMBL4924	Homo sapiens	Activity	%	5.8
	2938440	CHEMBL1036948	Inhibition of RSK4 at 1 uM	B	Cc1cnc(Nc2ccc(F)cc2Cl)nc1-c1c[nH]c(C(=O)N[C@H](CO)c2cccc(Cl)c2)c1		CHEMBL583042	=	Inhibition	%	11.0	CHEMBL4924	Homo sapiens	INH	%	11.0
	3052476	CHEMBL1072514	Residual activity of RPS6KA6 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	95.0	CHEMBL4924	Homo sapiens	Residual activity	%	95.0
	3052728	CHEMBL1043807	Residual activity of RPS6KA6 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	97.0	CHEMBL4924	Homo sapiens	Residual activity	%	97.0
	3054037	CHEMBL1071367	Residual activity of RPS6KA6 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	32.0	CHEMBL4924	Homo sapiens	Residual activity	%	32.0
	3055324	CHEMBL1072514	Residual activity of RPS6KA6 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL4924	Homo sapiens	Residual activity	%	96.0
	3055576	CHEMBL1043807	Residual activity of RPS6KA6 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	101.0	CHEMBL4924	Homo sapiens	Residual activity	%	101.0
	3056881	CHEMBL1071367	Residual activity of RPS6KA6 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	35.0	CHEMBL4924	Homo sapiens	Residual activity	%	35.0
	3057133	CHEMBL1072514	Residual activity of RPS6KA6 at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	92.0	CHEMBL4924	Homo sapiens	Residual activity	%	92.0
	3058453	CHEMBL1043807	Residual activity of RPS6KA6 at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	95.0	CHEMBL4924	Homo sapiens	Residual activity	%	95.0
	3059737	CHEMBL1071367	Residual activity of RPS6KA6 at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	50.0	CHEMBL4924	Homo sapiens	Residual activity	%	50.0
	3214040	CHEMBL1103235	Inhibition of RSK4 at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	17.0	CHEMBL4924	Homo sapiens	INH	%	17.0
	3224957	CHEMBL1101761	Inhibition of RSK4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1-c1cnc(CO)cn1		CHEMBL1081678	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3226336	CHEMBL1101761	Inhibition of RSK4 at 10 uM	B	Cc1cc(OCc2ccc(F)cc2F)c(Br)c(=O)n1Cc1ccc(CN(C)C)cc1		CHEMBL1078665	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3332147	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3332148	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3333562	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3333563	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3334967	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3334968	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3336387	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3336388	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3337650	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3337651	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	O=C(O)c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1		CHEMBL1163510	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3338981	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3338982	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCCCC1		CHEMBL1163518	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3339235	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3339236	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	COC1CCN(C(=O)c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cc2)CC1		CHEMBL1163567	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3340538	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3340539	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	O=C(c1ccc(-c2cnc3c(c2)N(Cc2cc(Cl)ccc2C(F)(F)F)CCN3)cc1)N1CCC(N2CCCC2)CC1		CHEMBL1163559	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3341929	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3341930	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3343376	CHEMBL1167695	Inhibition of RPS6KA6 N-terminal domain1 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3343377	CHEMBL1167696	Inhibition of RPS6KA6 C-terminal domain2 at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	3358803	CHEMBL1175331	Inhibition of RSK4 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	47.0	CHEMBL4924	Homo sapiens	INH	%	47.0
	3358804	CHEMBL1175332	Inhibition of RSK4 C-terminal domain2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	6.8	CHEMBL4924	Homo sapiens	INH	%	6.8
	3359245	CHEMBL1175331	Inhibition of RSK4 N-terminal domain1 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	28.0	CHEMBL4924	Homo sapiens	INH	%	28.0
	3359246	CHEMBL1175332	Inhibition of RSK4 C-terminal domain2 at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	29.0	CHEMBL4924	Homo sapiens	INH	%	29.0
	3443520	CHEMBL1244286	Inhibition of RSK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc(Br)c(O)c2)c2c(N)ncnc21		CHEMBL1241578	=	Inhibition	%	23.0	CHEMBL4924	Homo sapiens	INH	%	23.0
	3443737	CHEMBL1244286	Inhibition of RSK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	Nc1ncnc2c1c(-c1cnc3[nH]ccc3c1)nn2C1CCCC1		CHEMBL1081312	=	Inhibition	%	8.0	CHEMBL4924	Homo sapiens	INH	%	8.0
	3444892	CHEMBL1244286	Inhibition of RSK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2ccc3ncccc3c2)c2c(N)ncnc21		CHEMBL1233882	=	Inhibition	%	11.0	CHEMBL4924	Homo sapiens	INH	%	11.0
	3445298	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	110.0	CHEMBL4924	Homo sapiens	Kd	nM	110.0
	3445516	CHEMBL1244286	Inhibition of RSK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC		CHEMBL1233881	=	Inhibition	%	8.0	CHEMBL4924	Homo sapiens	INH	%	8.0
	3445733	CHEMBL1244286	Inhibition of RSK4 at 1 uM after 60 mins by FRET assay in presence of 10 uM ATP	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Inhibition	%	52.0	CHEMBL4924	Homo sapiens	INH	%	52.0
	3448620	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3448621	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3449046	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1500.0	CHEMBL4924	Homo sapiens	Kd	nM	1500.0
	3449506	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2400.0	CHEMBL4924	Homo sapiens	Kd	nM	2400.0
	3449507	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7500.0	CHEMBL4924	Homo sapiens	Kd	nM	7500.0
	3449847	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3449848	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3449959	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3450239	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3450413	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3450864	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3451148	CHEMBL1244973	Binding affinity to RPS6KA6(Kin.Dom.1-N-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3451149	CHEMBL1244974	Binding affinity to RPS6KA6(Kin.Dom.2-C-terminal)	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	uM	10.0
	3463353	CHEMBL1251686	Inhibition of RPS6KA6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4c[nH]c5ccccc45)c3)cc12		CHEMBL379300	=	Inhibition	%	87.0	CHEMBL4924	Homo sapiens	INH	%	87.0
	3463897	CHEMBL1251686	Inhibition of RPS6KA6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	COc1ccccc1N1CCN(c2ncnc3[nH]nc(Br)c23)CC1		CHEMBL1254209	=	Inhibition	%	28.0	CHEMBL4924	Homo sapiens	INH	%	28.0
	3464116	CHEMBL1251686	Inhibition of RPS6KA6 at 1 uM in presence of 10 uM ATP by Select Screen kinase assay relative to untreated control	B	O=C(NCCCNc1nc(Nc2cccc(NC(=O)N3CCCC3)c2)ncc1I)c1cccs1		CHEMBL577784	=	Inhibition	%	58.0	CHEMBL4924	Homo sapiens	INH	%	58.0
	5123821	CHEMBL1645765	Inhibition of RPS6KA6 kinase domain1 at 1 uM	B	CCN1C(=O)CCC(C)(C)c2ccc(Nc3ncc(Cl)c(Nc4c(F)cccc4C(=O)NC)n3)cc21		CHEMBL1644812	=	Inhibition	%	95.0	CHEMBL4924	Homo sapiens	INH	%	95.0
	5223300	CHEMBL1679290	Binding affinity to RPS6KA6 at 10 uM by immobilized ligand displacement assay	B	COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C		CHEMBL1673039	>	Inhibition	%	90.0	CHEMBL4924	Homo sapiens	INH	%	90.0
	6169191	CHEMBL1768794	Inhibition of human RSK4 assessed as residual activity at 10 uM	B	CNc1nc(-c2ccc3c(N)n[nH]c3c2)cc(N2C[C@@H](C(=O)NC3CCCCC3)CC[C@H]2C)n1		CHEMBL1765740	=	Activity	%	12.0	CHEMBL4924	Homo sapiens	Activity	%	12.0
	6339953	CHEMBL1826636	Activity of RPS6KA6(Kin.Dom.2-Cterminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	80.0	CHEMBL4924	Homo sapiens	Activity	%	80.0
	6340014	CHEMBL1827252	Activity of RPS6KA6(Kin.Dom.1-Nterminal) kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	87.0	CHEMBL4924	Homo sapiens	Activity	%	87.0
	6385583	CHEMBL1837950	Inhibition of human RSK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCCc2ccccc2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CC1		CHEMBL1834114	<	Inhibition	%	35.0	CHEMBL4924	Homo sapiens	INH	%	35.0
	6385584	CHEMBL1837950	Inhibition of human RSK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c(F)c2c1c(=O)c(C(=O)O)cn2C1CCCC1		CHEMBL1834318	<	Inhibition	%	35.0	CHEMBL4924	Homo sapiens	INH	%	35.0
	6385585	CHEMBL1837950	Inhibition of human RSK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	C[C@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834323	<	Inhibition	%	35.0	CHEMBL4924	Homo sapiens	INH	%	35.0
	6385586	CHEMBL1837950	Inhibition of human RSK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	CC(C)[C@@H]1COc2c(NCCNc3ccccn3)c(F)c(N)c3c(=O)c(C(=O)O)cn1c23		CHEMBL1834324	<	Inhibition	%	35.0	CHEMBL4924	Homo sapiens	INH	%	35.0
	6385587	CHEMBL1837950	Inhibition of human RSK4 in HL60 cells lysate at 10 uM using post probe-labeling by LC-MS/MS analysis relative to control	B	Nc1c(F)c(NCCNc2ccccn2)c2c3c1c(=O)c(C(=O)O)cn3C1(CCCC1)CO2		CHEMBL1834330	<	Inhibition	%	35.0	CHEMBL4924	Homo sapiens	INH	%	35.0
	7567498	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7567499	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7567969	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7567970	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7568437	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7568438	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7568869	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	=	Kd	nM	3100.0	CHEMBL4924	Homo sapiens	Kd	nM	3100.0
	7568870	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7569012	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7569013	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7569472	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7569473	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	=	Kd	nM	540.0	CHEMBL4924	Homo sapiens	Kd	nM	540.0
	7569944	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7569945	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7570407	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	=	Kd	nM	6800.0	CHEMBL4924	Homo sapiens	Kd	nM	6800.0
	7570408	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7570834	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	=	Kd	nM	2400.0	CHEMBL4924	Homo sapiens	Kd	nM	2400.0
	7570835	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7570988	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7570989	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7571445	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7571446	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7571921	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	1400.0	CHEMBL4924	Homo sapiens	Kd	nM	1400.0
	7571922	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	=	Kd	nM	150.0	CHEMBL4924	Homo sapiens	Kd	nM	150.0
	7572384	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7572385	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7572800	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	27.0	CHEMBL4924	Homo sapiens	Kd	nM	27.0
	7572801	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	160.0	CHEMBL4924	Homo sapiens	Kd	nM	160.0
	7572969	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7572970	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1300.0	CHEMBL4924	Homo sapiens	Kd	nM	1300.0
	7573426	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7573427	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7573902	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	3000.0	CHEMBL4924	Homo sapiens	Kd	nM	3000.0
	7573903	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7574371	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	1500.0	CHEMBL4924	Homo sapiens	Kd	nM	1500.0
	7574372	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7574947	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	=	Kd	nM	230.0	CHEMBL4924	Homo sapiens	Kd	nM	230.0
	7574948	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7575408	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7575409	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7575879	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7575880	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7576310	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7576311	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	=	Kd	nM	970.0	CHEMBL4924	Homo sapiens	Kd	nM	970.0
	7576921	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7576922	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	3100.0	CHEMBL4924	Homo sapiens	Kd	nM	3100.0
	7577380	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7577381	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7577886	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7577887	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7578291	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7578292	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	=	Kd	nM	360.0	CHEMBL4924	Homo sapiens	Kd	nM	360.0
	7578929	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7578930	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7579303	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7579304	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7579753	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2100.0	CHEMBL4924	Homo sapiens	Kd	nM	2100.0
	7579754	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	800.0	CHEMBL4924	Homo sapiens	Kd	nM	800.0
	7579785	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	=	Kd	nM	440.0	CHEMBL4924	Homo sapiens	Kd	nM	440.0
	7579786	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7580254	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	610.0	CHEMBL4924	Homo sapiens	Kd	nM	610.0
	7580255	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	=	Kd	nM	7300.0	CHEMBL4924	Homo sapiens	Kd	nM	7300.0
	7580657	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7580658	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	=	Kd	nM	240.0	CHEMBL4924	Homo sapiens	Kd	nM	240.0
	7581287	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7581288	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7581672	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7581673	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	=	Kd	nM	6700.0	CHEMBL4924	Homo sapiens	Kd	nM	6700.0
	7582146	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7582147	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7582610	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7582611	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7583010	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7583011	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7584033	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7584034	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7584504	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	=	Kd	nM	25.0	CHEMBL4924	Homo sapiens	Kd	nM	25.0
	7584505	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7584966	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7584967	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7585370	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7585371	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7585521	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7585522	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7585929	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7585930	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7586375	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	=	Kd	nM	5400.0	CHEMBL4924	Homo sapiens	Kd	nM	5400.0
	7586376	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7586846	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	2300.0	CHEMBL4924	Homo sapiens	Kd	nM	2300.0
	7586847	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7587300	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7587301	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7587482	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7587483	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7587901	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7587902	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7588354	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7588355	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7588825	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7588826	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7589276	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7589277	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Kd	nM	250.0	CHEMBL4924	Homo sapiens	Kd	nM	250.0
	7589447	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7589448	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7589871	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	110.0	CHEMBL4924	Homo sapiens	Kd	nM	110.0
	7589872	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	9100.0	CHEMBL4924	Homo sapiens	Kd	nM	9100.0
	7590338	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	=	Kd	nM	3000.0	CHEMBL4924	Homo sapiens	Kd	nM	3000.0
	7590339	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7590812	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7590813	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7591420	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7591421	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7591842	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	=	Kd	nM	4600.0	CHEMBL4924	Homo sapiens	Kd	nM	4600.0
	7591843	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7592314	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	350.0	CHEMBL4924	Homo sapiens	Kd	nM	350.0
	7592315	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7592798	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7592799	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7593387	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7593388	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	=	Kd	nM	3400.0	CHEMBL4924	Homo sapiens	Kd	nM	3400.0
	7593822	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7593823	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7594294	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7594295	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7594325	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7594326	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7594777	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	2700.0	CHEMBL4924	Homo sapiens	Kd	nM	2700.0
	7594778	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7595355	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7595356	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7595799	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7595800	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7596302	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7596303	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7596749	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7596750	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	=	Kd	nM	7500.0	CHEMBL4924	Homo sapiens	Kd	nM	7500.0
	7597327	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7597328	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7597811	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7597812	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7598281	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7598282	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4924	Homo sapiens	Kd	nM	10000.0
	7598723	CHEMBL1908778	Binding constant for RSK4(Kin.Dom.1-N-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	18.0	CHEMBL4924	Homo sapiens	Kd	nM	18.0
	7598724	CHEMBL1908779	Binding constant for RSK4(Kin.Dom.2-C-terminal) kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	3300.0	CHEMBL4924	Homo sapiens	Kd	nM	3300.0
	7922648	CHEMBL1919000	Inhibition of human recombinant RPS6KA6 at 0.5 uM by radiometric filter-binding assay	B	Clc1ccccc1Nc1nc2c(-c3nnc[nH]3)cccc2c2cnccc12		CHEMBL1915438	=	Inhibition	%	88.0	CHEMBL4924	Homo sapiens	INH	%	88.0
	8061248	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.47	CHEMBL4924	Homo sapiens	Inhibition	%	0.47
	8061425	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	2.26	CHEMBL4924	Homo sapiens	Inhibition	%	2.26
	8061649	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.23	CHEMBL4924	Homo sapiens	Inhibition	%	0.23
	8061756	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	2.69	CHEMBL4924	Homo sapiens	Inhibition	%	2.69
	8061947	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.64	CHEMBL4924	Homo sapiens	Inhibition	%	2.64
	8062171	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	10.19	CHEMBL4924	Homo sapiens	Inhibition	%	10.19
	8062287	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	2.49	CHEMBL4924	Homo sapiens	Inhibition	%	2.49
	8062673	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.31	CHEMBL4924	Homo sapiens	Inhibition	%	3.31
	8062771	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.11	CHEMBL4924	Homo sapiens	Inhibition	%	1.11
	8062995	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	0.51	CHEMBL4924	Homo sapiens	Inhibition	%	0.51
	8063127	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	0.03	CHEMBL4924	Homo sapiens	Inhibition	%	0.03
	8063518	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	0.85	CHEMBL4924	Homo sapiens	Inhibition	%	0.85
	8063626	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	0.71	CHEMBL4924	Homo sapiens	Inhibition	%	0.71
	8064032	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	1.4	CHEMBL4924	Homo sapiens	Inhibition	%	1.4
	8064147	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	5.91	CHEMBL4924	Homo sapiens	Inhibition	%	5.91
	8064371	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.31	CHEMBL4924	Homo sapiens	Inhibition	%	2.31
	8064581	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	1.1	CHEMBL4924	Homo sapiens	Inhibition	%	1.1
	8064719	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	0.4	CHEMBL4924	Homo sapiens	Inhibition	%	0.4
	8065109	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.83	CHEMBL4924	Homo sapiens	Inhibition	%	0.83
	8065225	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	1.4	CHEMBL4924	Homo sapiens	Inhibition	%	1.4
	8065449	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.97	CHEMBL4924	Homo sapiens	Inhibition	%	1.97
	8065624	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	2.56	CHEMBL4924	Homo sapiens	Inhibition	%	2.56
	8065963	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	15.2	CHEMBL4924	Homo sapiens	Inhibition	%	15.2
	8066173	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	-0.93	CHEMBL4924	Homo sapiens	Inhibition	%	-0.93
	8066309	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	3.67	CHEMBL4924	Homo sapiens	Inhibition	%	3.67
	8066533	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	0.97	CHEMBL4924	Homo sapiens	Inhibition	%	0.97
	8066699	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.85	CHEMBL4924	Homo sapiens	Inhibition	%	0.85
	8067047	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	1.35	CHEMBL4924	Homo sapiens	Inhibition	%	1.35
	8067222	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	0.08	CHEMBL4924	Homo sapiens	Inhibition	%	0.08
	8067567	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.1	CHEMBL4924	Homo sapiens	Inhibition	%	1.1
	8067777	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	0.92	CHEMBL4924	Homo sapiens	Inhibition	%	0.92
	8068136	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	6.06	CHEMBL4924	Homo sapiens	Inhibition	%	6.06
	8068300	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.19	CHEMBL4924	Homo sapiens	Inhibition	%	-0.19
	8068649	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	-0.96	CHEMBL4924	Homo sapiens	Inhibition	%	-0.96
	8068823	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	1.27	CHEMBL4924	Homo sapiens	Inhibition	%	1.27
	8069047	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	0.84	CHEMBL4924	Homo sapiens	Inhibition	%	0.84
	8069172	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.09	CHEMBL4924	Homo sapiens	Inhibition	%	2.09
	8069467	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.17	CHEMBL4924	Homo sapiens	Inhibition	%	5.17
	8069628	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	-0.13	CHEMBL4924	Homo sapiens	Inhibition	%	-0.13
	8069852	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	0.74	CHEMBL4924	Homo sapiens	Inhibition	%	0.74
	8069978	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	0.81	CHEMBL4924	Homo sapiens	Inhibition	%	0.81
	8070374	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	1.25	CHEMBL4924	Homo sapiens	Inhibition	%	1.25
	8070499	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	0.05	CHEMBL4924	Homo sapiens	Inhibition	%	0.05
	8070797	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	27.89	CHEMBL4924	Homo sapiens	Inhibition	%	27.89
	8071178	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.2	CHEMBL4924	Homo sapiens	Inhibition	%	1.2
	8071304	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.98	CHEMBL4924	Homo sapiens	Inhibition	%	0.98
	8071528	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.71	CHEMBL4924	Homo sapiens	Inhibition	%	1.71
	8071701	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	0.15	CHEMBL4924	Homo sapiens	Inhibition	%	0.15
	8071826	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	-0.11	CHEMBL4924	Homo sapiens	Inhibition	%	-0.11
	8072050	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	0.36	CHEMBL4924	Homo sapiens	Inhibition	%	0.36
	8072140	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	-0.63	CHEMBL4924	Homo sapiens	Inhibition	%	-0.63
	8072364	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.04	CHEMBL4924	Homo sapiens	Inhibition	%	1.04
	8072521	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.27	CHEMBL4924	Homo sapiens	Inhibition	%	1.27
	8072870	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	-0.29	CHEMBL4924	Homo sapiens	Inhibition	%	-0.29
	8073037	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	2.56	CHEMBL4924	Homo sapiens	Inhibition	%	2.56
	8073386	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.65	CHEMBL4924	Homo sapiens	Inhibition	%	1.65
	8073505	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.62	CHEMBL4924	Homo sapiens	Inhibition	%	1.62
	8073729	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	2.46	CHEMBL4924	Homo sapiens	Inhibition	%	2.46
	8073962	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.28	CHEMBL4924	Homo sapiens	Inhibition	%	0.28
	8074114	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	0.36	CHEMBL4924	Homo sapiens	Inhibition	%	0.36
	8074468	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.1	CHEMBL4924	Homo sapiens	Inhibition	%	0.1
	8074625	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	1.6	CHEMBL4924	Homo sapiens	Inhibition	%	1.6
	8074849	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	2.01	CHEMBL4924	Homo sapiens	Inhibition	%	2.01
	8074976	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.58	CHEMBL4924	Homo sapiens	Inhibition	%	0.58
	8075311	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	0.43	CHEMBL4924	Homo sapiens	Inhibition	%	0.43
	8075548	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	0.64	CHEMBL4924	Homo sapiens	Inhibition	%	0.64
	8075689	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	1.24	CHEMBL4924	Homo sapiens	Inhibition	%	1.24
	8075913	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.09	CHEMBL4924	Homo sapiens	Inhibition	%	3.09
	8076055	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.31	CHEMBL4924	Homo sapiens	Inhibition	%	1.31
	8076427	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	1.48	CHEMBL4924	Homo sapiens	Inhibition	%	1.48
	8076561	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	2.88	CHEMBL4924	Homo sapiens	Inhibition	%	2.88
	8076887	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.21	CHEMBL4924	Homo sapiens	Inhibition	%	-0.21
	8077134	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	4.01	CHEMBL4924	Homo sapiens	Inhibition	%	4.01
	8077486	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	0.0	CHEMBL4924	Homo sapiens	Inhibition	%	0.0
	8077637	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	9.8	CHEMBL4924	Homo sapiens	Inhibition	%	9.8
	8078004	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.25	CHEMBL4924	Homo sapiens	Inhibition	%	2.25
	8078143	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	13.44	CHEMBL4924	Homo sapiens	Inhibition	%	13.44
	8078367	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	59.46	CHEMBL4924	Homo sapiens	Inhibition	%	59.46
	8078469	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	0.13	CHEMBL4924	Homo sapiens	Inhibition	%	0.13
	8078719	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	23.4	CHEMBL4924	Homo sapiens	Inhibition	%	23.4
	8079059	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	1.23	CHEMBL4924	Homo sapiens	Inhibition	%	1.23
	8079217	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.4	CHEMBL4924	Homo sapiens	Inhibition	%	-0.4
	8079441	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	12.68	CHEMBL4924	Homo sapiens	Inhibition	%	12.68
	8079583	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.96	CHEMBL4924	Homo sapiens	Inhibition	%	0.96
	8079946	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	23.37	CHEMBL4924	Homo sapiens	Inhibition	%	23.37
	8080051	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	-0.49	CHEMBL4924	Homo sapiens	Inhibition	%	-0.49
	8080303	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	4.96	CHEMBL4924	Homo sapiens	Inhibition	%	4.96
	8080527	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	39.31	CHEMBL4924	Homo sapiens	Inhibition	%	39.31
	8080642	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	1.03	CHEMBL4924	Homo sapiens	Inhibition	%	1.03
	8081030	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.38	CHEMBL4924	Homo sapiens	Inhibition	%	-2.38
	8081165	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	0.29	CHEMBL4924	Homo sapiens	Inhibition	%	0.29
	8081533	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	63.37	CHEMBL4924	Homo sapiens	Inhibition	%	63.37
	8081636	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	3.63	CHEMBL4924	Homo sapiens	Inhibition	%	3.63
	8081860	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	21.47	CHEMBL4924	Homo sapiens	Inhibition	%	21.47
	8082112	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	6.78	CHEMBL4924	Homo sapiens	Inhibition	%	6.78
	8082225	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	0.55	CHEMBL4924	Homo sapiens	Inhibition	%	0.55
	8082449	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	1.08	CHEMBL4924	Homo sapiens	Inhibition	%	1.08
	8082622	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	4.21	CHEMBL4924	Homo sapiens	Inhibition	%	4.21
	8082745	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.63	CHEMBL4924	Homo sapiens	Inhibition	%	1.63
	8082969	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	1.08	CHEMBL4924	Homo sapiens	Inhibition	%	1.08
	8083125	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.05	CHEMBL4924	Homo sapiens	Inhibition	%	3.05
	8083448	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.24	CHEMBL4924	Homo sapiens	Inhibition	%	1.24
	8083702	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	30.95	CHEMBL4924	Homo sapiens	Inhibition	%	30.95
	8084036	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.17	CHEMBL4924	Homo sapiens	Inhibition	%	3.17
	8084221	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	12.96	CHEMBL4924	Homo sapiens	Inhibition	%	12.96
	8084563	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	0.97	CHEMBL4924	Homo sapiens	Inhibition	%	0.97
	8084724	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	13.04	CHEMBL4924	Homo sapiens	Inhibition	%	13.04
	8085046	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	1.64	CHEMBL4924	Homo sapiens	Inhibition	%	1.64
	8085302	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-1.29	CHEMBL4924	Homo sapiens	Inhibition	%	-1.29
	8085634	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.17	CHEMBL4924	Homo sapiens	Inhibition	%	3.17
	8085823	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	55.46	CHEMBL4924	Homo sapiens	Inhibition	%	55.46
	8086162	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	1.71	CHEMBL4924	Homo sapiens	Inhibition	%	1.71
	8086324	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	2.77	CHEMBL4924	Homo sapiens	Inhibition	%	2.77
	8086548	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	12.69	CHEMBL4924	Homo sapiens	Inhibition	%	12.69
	8086647	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	1.33	CHEMBL4924	Homo sapiens	Inhibition	%	1.33
	8086858	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	0.73	CHEMBL4924	Homo sapiens	Inhibition	%	0.73
	8087082	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	1.63	CHEMBL4924	Homo sapiens	Inhibition	%	1.63
	8087240	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	0.01	CHEMBL4924	Homo sapiens	Inhibition	%	0.01
	8087578	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.08	CHEMBL4924	Homo sapiens	Inhibition	%	0.08
	8087716	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	2.87	CHEMBL4924	Homo sapiens	Inhibition	%	2.87
	8087940	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-0.22	CHEMBL4924	Homo sapiens	Inhibition	%	-0.22
	8088082	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	2.55	CHEMBL4924	Homo sapiens	Inhibition	%	2.55
	8088230	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	-1.16	CHEMBL4924	Homo sapiens	Inhibition	%	-1.16
	8088454	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.06	CHEMBL4924	Homo sapiens	Inhibition	%	0.06
	8088582	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.81	CHEMBL4924	Homo sapiens	Inhibition	%	1.81
	8088899	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	10.36	CHEMBL4924	Homo sapiens	Inhibition	%	10.36
	8089251	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	4.14	CHEMBL4924	Homo sapiens	Inhibition	%	4.14
	8089399	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	1.61	CHEMBL4924	Homo sapiens	Inhibition	%	1.61
	8089743	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	2.01	CHEMBL4924	Homo sapiens	Inhibition	%	2.01
	8089923	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.48	CHEMBL4924	Homo sapiens	Inhibition	%	-1.48
	8090312	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	11.71	CHEMBL4924	Homo sapiens	Inhibition	%	11.71
	8090479	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.39	CHEMBL4924	Homo sapiens	Inhibition	%	2.39
	8090842	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.26	CHEMBL4924	Homo sapiens	Inhibition	%	-0.26
	8091047	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	2.96	CHEMBL4924	Homo sapiens	Inhibition	%	2.96
	8091408	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	11.74	CHEMBL4924	Homo sapiens	Inhibition	%	11.74
	8091563	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	1.25	CHEMBL4924	Homo sapiens	Inhibition	%	1.25
	8091903	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	0.95	CHEMBL4924	Homo sapiens	Inhibition	%	0.95
	8092264	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.23	CHEMBL4924	Homo sapiens	Inhibition	%	-1.23
	8092415	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	0.77	CHEMBL4924	Homo sapiens	Inhibition	%	0.77
	8092787	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.01	CHEMBL4924	Homo sapiens	Inhibition	%	-0.01
	8092916	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	6.8	CHEMBL4924	Homo sapiens	Inhibition	%	6.8
	8093140	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.03	CHEMBL4924	Homo sapiens	Inhibition	%	0.03
	8093228	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	0.24	CHEMBL4924	Homo sapiens	Inhibition	%	0.24
	8093592	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	2.62	CHEMBL4924	Homo sapiens	Inhibition	%	2.62
	8093731	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	13.61	CHEMBL4924	Homo sapiens	Inhibition	%	13.61
	8093955	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.08	CHEMBL4924	Homo sapiens	Inhibition	%	0.08
	8094075	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.92	CHEMBL4924	Homo sapiens	Inhibition	%	3.92
	8094255	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.24	CHEMBL4924	Homo sapiens	Inhibition	%	-0.24
	8094479	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.53	CHEMBL4924	Homo sapiens	Inhibition	%	-0.53
	8094654	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	14.46	CHEMBL4924	Homo sapiens	Inhibition	%	14.46
	8094810	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	12.82	CHEMBL4924	Homo sapiens	Inhibition	%	12.82
	8095034	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.43	CHEMBL4924	Homo sapiens	Inhibition	%	2.43
	8095174	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	-0.89	CHEMBL4924	Homo sapiens	Inhibition	%	-0.89
	8095377	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.11	CHEMBL4924	Homo sapiens	Inhibition	%	1.11
	8095601	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.23	CHEMBL4924	Homo sapiens	Inhibition	%	1.23
	8095742	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	38.85	CHEMBL4924	Homo sapiens	Inhibition	%	38.85
	8095890	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.46	CHEMBL4924	Homo sapiens	Inhibition	%	1.46
	8096114	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	1.92	CHEMBL4924	Homo sapiens	Inhibition	%	1.92
	8096231	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.51	CHEMBL4924	Homo sapiens	Inhibition	%	0.51
	8096594	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-1.76	CHEMBL4924	Homo sapiens	Inhibition	%	-1.76
	8096750	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	2.5	CHEMBL4924	Homo sapiens	Inhibition	%	2.5
	8096974	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	2.25	CHEMBL4924	Homo sapiens	Inhibition	%	2.25
	8097121	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	0.4	CHEMBL4924	Homo sapiens	Inhibition	%	0.4
	8097428	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	2.38	CHEMBL4924	Homo sapiens	Inhibition	%	2.38
	8097652	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	1.63	CHEMBL4924	Homo sapiens	Inhibition	%	1.63
	8097802	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	17.46	CHEMBL4924	Homo sapiens	Inhibition	%	17.46
	8098159	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	1.45	CHEMBL4924	Homo sapiens	Inhibition	%	1.45
	8098279	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	1.09	CHEMBL4924	Homo sapiens	Inhibition	%	1.09
	8098683	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	0.12	CHEMBL4924	Homo sapiens	Inhibition	%	0.12
	8098868	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	54.82	CHEMBL4924	Homo sapiens	Inhibition	%	54.82
	8099236	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	2.32	CHEMBL4924	Homo sapiens	Inhibition	%	2.32
	8099378	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.64	CHEMBL4924	Homo sapiens	Inhibition	%	1.64
	8099796	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	1.24	CHEMBL4924	Homo sapiens	Inhibition	%	1.24
	8099943	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	0.68	CHEMBL4924	Homo sapiens	Inhibition	%	0.68
	8100313	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	0.03	CHEMBL4924	Homo sapiens	Inhibition	%	0.03
	8100429	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	0.63	CHEMBL4924	Homo sapiens	Inhibition	%	0.63
	8100653	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.67	CHEMBL4924	Homo sapiens	Inhibition	%	0.67
	8100793	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.67	CHEMBL4924	Homo sapiens	Inhibition	%	-0.67
	8101177	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	3.03	CHEMBL4924	Homo sapiens	Inhibition	%	3.03
	8101319	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	0.47	CHEMBL4924	Homo sapiens	Inhibition	%	0.47
	8101728	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	3.6	CHEMBL4924	Homo sapiens	Inhibition	%	3.6
	8101981	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	10.63	CHEMBL4924	Homo sapiens	Inhibition	%	10.63
	8102136	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	0.56	CHEMBL4924	Homo sapiens	Inhibition	%	0.56
	8102491	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	1.64	CHEMBL4924	Homo sapiens	Inhibition	%	1.64
	8102611	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	2.04	CHEMBL4924	Homo sapiens	Inhibition	%	2.04
	8102835	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.3	CHEMBL4924	Homo sapiens	Inhibition	%	-1.3
	8103013	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	-0.53	CHEMBL4924	Homo sapiens	Inhibition	%	-0.53
	8103209	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8103571	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	1.27	CHEMBL4924	Homo sapiens	Inhibition	%	1.27
	8103721	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	1.71	CHEMBL4924	Homo sapiens	Inhibition	%	1.71
	8103945	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	0.81	CHEMBL4924	Homo sapiens	Inhibition	%	0.81
	8104130	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.53	CHEMBL4924	Homo sapiens	Inhibition	%	-0.53
	8104278	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	3.14	CHEMBL4924	Homo sapiens	Inhibition	%	3.14
	8104502	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	8.06	CHEMBL4924	Homo sapiens	Inhibition	%	8.06
	8104648	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	5.02	CHEMBL4924	Homo sapiens	Inhibition	%	5.02
	8104986	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	0.97	CHEMBL4924	Homo sapiens	Inhibition	%	0.97
	8105126	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-0.75	CHEMBL4924	Homo sapiens	Inhibition	%	-0.75
	8105350	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.04	CHEMBL4924	Homo sapiens	Inhibition	%	0.04
	8105516	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	7.23	CHEMBL4924	Homo sapiens	Inhibition	%	7.23
	8105654	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	6.6	CHEMBL4924	Homo sapiens	Inhibition	%	6.6
	8105878	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	0.85	CHEMBL4924	Homo sapiens	Inhibition	%	0.85
	8105934	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	0.92	CHEMBL4924	Homo sapiens	Inhibition	%	0.92
	8106158	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	1.39	CHEMBL4924	Homo sapiens	Inhibition	%	1.39
	8106323	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	0.86	CHEMBL4924	Homo sapiens	Inhibition	%	0.86
	8106479	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	9.04	CHEMBL4924	Homo sapiens	Inhibition	%	9.04
	8106703	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	1.06	CHEMBL4924	Homo sapiens	Inhibition	%	1.06
	8106832	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.89	CHEMBL4924	Homo sapiens	Inhibition	%	2.89
	8107177	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-1.2	CHEMBL4924	Homo sapiens	Inhibition	%	-1.2
	8107349	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.36	CHEMBL4924	Homo sapiens	Inhibition	%	1.36
	8107550	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	7.07	CHEMBL4924	Homo sapiens	Inhibition	%	7.07
	8107774	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	1.32	CHEMBL4924	Homo sapiens	Inhibition	%	1.32
	8107909	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	6.03	CHEMBL4924	Homo sapiens	Inhibition	%	6.03
	8108291	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.47	CHEMBL4924	Homo sapiens	Inhibition	%	1.47
	8108466	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-1.02	CHEMBL4924	Homo sapiens	Inhibition	%	-1.02
	8108837	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	42.42	CHEMBL4924	Homo sapiens	Inhibition	%	42.42
	8108979	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-1.59	CHEMBL4924	Homo sapiens	Inhibition	%	-1.59
	8109317	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.82	CHEMBL4924	Homo sapiens	Inhibition	%	0.82
	8109671	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-1.65	CHEMBL4924	Homo sapiens	Inhibition	%	-1.65
	8109842	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	40.38	CHEMBL4924	Homo sapiens	Inhibition	%	40.38
	8110198	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.83	CHEMBL4924	Homo sapiens	Inhibition	%	2.83
	8110477	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	-0.04	CHEMBL4924	Homo sapiens	Inhibition	%	-0.04
	8110643	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	2.42	CHEMBL4924	Homo sapiens	Inhibition	%	2.42
	8111025	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	15.3	CHEMBL4924	Homo sapiens	Inhibition	%	15.3
	8111148	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	-0.02	CHEMBL4924	Homo sapiens	Inhibition	%	-0.02
	8111499	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	-0.15	CHEMBL4924	Homo sapiens	Inhibition	%	-0.15
	8111665	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.95	CHEMBL4924	Homo sapiens	Inhibition	%	1.95
	8111889	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	1.62	CHEMBL4924	Homo sapiens	Inhibition	%	1.62
	8112094	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	2.13	CHEMBL4924	Homo sapiens	Inhibition	%	2.13
	8112231	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	-0.47	CHEMBL4924	Homo sapiens	Inhibition	%	-0.47
	8112455	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	0.03	CHEMBL4924	Homo sapiens	Inhibition	%	0.03
	8112623	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	2.34	CHEMBL4924	Homo sapiens	Inhibition	%	2.34
	8112795	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.31	CHEMBL4924	Homo sapiens	Inhibition	%	-0.31
	8113171	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	0.98	CHEMBL4924	Homo sapiens	Inhibition	%	0.98
	8113307	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	-0.62	CHEMBL4924	Homo sapiens	Inhibition	%	-0.62
	8113531	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.67	CHEMBL4924	Homo sapiens	Inhibition	%	-0.67
	8113655	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.92	CHEMBL4924	Homo sapiens	Inhibition	%	0.92
	8113995	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	0.12	CHEMBL4924	Homo sapiens	Inhibition	%	0.12
	8114171	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	0.05	CHEMBL4924	Homo sapiens	Inhibition	%	0.05
	8114527	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.33	CHEMBL4924	Homo sapiens	Inhibition	%	1.33
	8114803	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	1.2	CHEMBL4924	Homo sapiens	Inhibition	%	1.2
	8114969	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	-2.74	CHEMBL4924	Homo sapiens	Inhibition	%	-2.74
	8115193	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	9.97	CHEMBL4924	Homo sapiens	Inhibition	%	9.97
	8115358	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.1	CHEMBL4924	Homo sapiens	Inhibition	%	0.1
	8115478	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	1.25	CHEMBL4924	Homo sapiens	Inhibition	%	1.25
	8115702	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	0.69	CHEMBL4924	Homo sapiens	Inhibition	%	0.69
	8115835	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	8.09	CHEMBL4924	Homo sapiens	Inhibition	%	8.09
	8116218	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	9.45	CHEMBL4924	Homo sapiens	Inhibition	%	9.45
	8116421	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	1.98	CHEMBL4924	Homo sapiens	Inhibition	%	1.98
	8116779	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	-0.83	CHEMBL4924	Homo sapiens	Inhibition	%	-0.83
	8116951	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	3.24	CHEMBL4924	Homo sapiens	Inhibition	%	3.24
	8117122	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	-0.72	CHEMBL4924	Homo sapiens	Inhibition	%	-0.72
	8117346	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	3.11	CHEMBL4924	Homo sapiens	Inhibition	%	3.11
	8117504	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	2.45	CHEMBL4924	Homo sapiens	Inhibition	%	2.45
	8117858	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.49	CHEMBL4924	Homo sapiens	Inhibition	%	0.49
	8117996	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.29	CHEMBL4924	Homo sapiens	Inhibition	%	0.29
	8118336	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	2.25	CHEMBL4924	Homo sapiens	Inhibition	%	2.25
	8118508	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	1.68	CHEMBL4924	Homo sapiens	Inhibition	%	1.68
	8118732	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	1.37	CHEMBL4924	Homo sapiens	Inhibition	%	1.37
	8118868	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	1.67	CHEMBL4924	Homo sapiens	Inhibition	%	1.67
	8119139	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.59	CHEMBL4924	Homo sapiens	Inhibition	%	3.59
	8119522	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	0.33	CHEMBL4924	Homo sapiens	Inhibition	%	0.33
	8119689	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.14	CHEMBL4924	Homo sapiens	Inhibition	%	-0.14
	8120032	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	1.36	CHEMBL4924	Homo sapiens	Inhibition	%	1.36
	8120171	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.18	CHEMBL4924	Homo sapiens	Inhibition	%	-0.18
	8120395	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	0.44	CHEMBL4924	Homo sapiens	Inhibition	%	0.44
	8120555	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.39	CHEMBL4924	Homo sapiens	Inhibition	%	-1.39
	8120756	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.51	CHEMBL4924	Homo sapiens	Inhibition	%	5.51
	8121108	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	0.17	CHEMBL4924	Homo sapiens	Inhibition	%	0.17
	8121280	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.78	CHEMBL4924	Homo sapiens	Inhibition	%	1.78
	8121671	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	7.42	CHEMBL4924	Homo sapiens	Inhibition	%	7.42
	8121834	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	2.09	CHEMBL4924	Homo sapiens	Inhibition	%	2.09
	8122179	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	0.37	CHEMBL4924	Homo sapiens	Inhibition	%	0.37
	8122317	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-0.02	CHEMBL4924	Homo sapiens	Inhibition	%	-0.02
	8122541	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	12.64	CHEMBL4924	Homo sapiens	Inhibition	%	12.64
	8122661	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.2	CHEMBL4924	Homo sapiens	Inhibition	%	3.2
	8123052	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	2.84	CHEMBL4924	Homo sapiens	Inhibition	%	2.84
	8123194	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	3.37	CHEMBL4924	Homo sapiens	Inhibition	%	3.37
	8123472	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	23.11	CHEMBL4924	Homo sapiens	Inhibition	%	23.11
	8123846	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	6.36	CHEMBL4924	Homo sapiens	Inhibition	%	6.36
	8124013	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-0.06	CHEMBL4924	Homo sapiens	Inhibition	%	-0.06
	8124356	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	-1.37	CHEMBL4924	Homo sapiens	Inhibition	%	-1.37
	8124719	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	1.82	CHEMBL4924	Homo sapiens	Inhibition	%	1.82
	8124884	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	-1.11	CHEMBL4924	Homo sapiens	Inhibition	%	-1.11
	8125085	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.18	CHEMBL4924	Homo sapiens	Inhibition	%	3.18
	8125309	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	3.1	CHEMBL4924	Homo sapiens	Inhibition	%	3.1
	8125439	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.32	CHEMBL4924	Homo sapiens	Inhibition	%	0.32
	8125607	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	1.25	CHEMBL4924	Homo sapiens	Inhibition	%	1.25
	8125831	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.72	CHEMBL4924	Homo sapiens	Inhibition	%	0.72
	8125995	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.8	CHEMBL4924	Homo sapiens	Inhibition	%	0.8
	8126159	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	5.17	CHEMBL4924	Homo sapiens	Inhibition	%	5.17
	8126383	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.43	CHEMBL4924	Homo sapiens	Inhibition	%	0.43
	8126498	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	5.9	CHEMBL4924	Homo sapiens	Inhibition	%	5.9
	8126858	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	59.88	CHEMBL4924	Homo sapiens	Inhibition	%	59.88
	8126980	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	2.38	CHEMBL4924	Homo sapiens	Inhibition	%	2.38
	8127204	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.14	CHEMBL4924	Homo sapiens	Inhibition	%	3.14
	8127371	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	2.2	CHEMBL4924	Homo sapiens	Inhibition	%	2.2
	8127513	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	23.62	CHEMBL4924	Homo sapiens	Inhibition	%	23.62
	8127737	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	-0.29	CHEMBL4924	Homo sapiens	Inhibition	%	-0.29
	8127801	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.59	CHEMBL4924	Homo sapiens	Inhibition	%	2.59
	8128025	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	13.19	CHEMBL4924	Homo sapiens	Inhibition	%	13.19
	8128177	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.12	CHEMBL4924	Homo sapiens	Inhibition	%	1.12
	8128344	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	1.9	CHEMBL4924	Homo sapiens	Inhibition	%	1.9
	8128568	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.95	CHEMBL4924	Homo sapiens	Inhibition	%	0.95
	8128687	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.34	CHEMBL4924	Homo sapiens	Inhibition	%	4.34
	8129048	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	11.19	CHEMBL4924	Homo sapiens	Inhibition	%	11.19
	8129219	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-0.45	CHEMBL4924	Homo sapiens	Inhibition	%	-0.45
	8129632	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	2.06	CHEMBL4924	Homo sapiens	Inhibition	%	2.06
	8129771	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.26	CHEMBL4924	Homo sapiens	Inhibition	%	0.26
	8130156	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.2	CHEMBL4924	Homo sapiens	Inhibition	%	0.2
	8130328	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.55	CHEMBL4924	Homo sapiens	Inhibition	%	0.55
	8130712	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	9.62	CHEMBL4924	Homo sapiens	Inhibition	%	9.62
	8130828	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.53	CHEMBL4924	Homo sapiens	Inhibition	%	0.53
	8131052	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	0.45	CHEMBL4924	Homo sapiens	Inhibition	%	0.45
	8131191	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	0.85	CHEMBL4924	Homo sapiens	Inhibition	%	0.85
	8131535	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.73	CHEMBL4924	Homo sapiens	Inhibition	%	0.73
	8131702	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	6.33	CHEMBL4924	Homo sapiens	Inhibition	%	6.33
	8132067	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	9.85	CHEMBL4924	Homo sapiens	Inhibition	%	9.85
	8132353	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.67	CHEMBL4924	Homo sapiens	Inhibition	%	1.67
	8132500	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	1.77	CHEMBL4924	Homo sapiens	Inhibition	%	1.77
	8132892	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	0.65	CHEMBL4924	Homo sapiens	Inhibition	%	0.65
	8133013	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	2.62	CHEMBL4924	Homo sapiens	Inhibition	%	2.62
	8133237	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	0.72	CHEMBL4924	Homo sapiens	Inhibition	%	0.72
	8133375	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.84	CHEMBL4924	Homo sapiens	Inhibition	%	1.84
	8133547	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	-1.99	CHEMBL4924	Homo sapiens	Inhibition	%	-1.99
	8133771	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-0.24	CHEMBL4924	Homo sapiens	Inhibition	%	-0.24
	8133951	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	5.11	CHEMBL4924	Homo sapiens	Inhibition	%	5.11
	8134099	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-0.28	CHEMBL4924	Homo sapiens	Inhibition	%	-0.28
	8134323	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	1.58	CHEMBL4924	Homo sapiens	Inhibition	%	1.58
	8134483	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.1	CHEMBL4924	Homo sapiens	Inhibition	%	-0.1
	8134667	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.95	CHEMBL4924	Homo sapiens	Inhibition	%	0.95
	8134891	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	11.0	CHEMBL4924	Homo sapiens	Inhibition	%	11.0
	8135051	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	-1.04	CHEMBL4924	Homo sapiens	Inhibition	%	-1.04
	8135390	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.89	CHEMBL4924	Homo sapiens	Inhibition	%	0.89
	8135531	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.52	CHEMBL4924	Homo sapiens	Inhibition	%	1.52
	8135876	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	0.39	CHEMBL4924	Homo sapiens	Inhibition	%	0.39
	8136044	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	0.2	CHEMBL4924	Homo sapiens	Inhibition	%	0.2
	8136268	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	1.54	CHEMBL4924	Homo sapiens	Inhibition	%	1.54
	8136412	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	0.63	CHEMBL4924	Homo sapiens	Inhibition	%	0.63
	8136702	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	4.74	CHEMBL4924	Homo sapiens	Inhibition	%	4.74
	8136837	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	0.12	CHEMBL4924	Homo sapiens	Inhibition	%	0.12
	8137061	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	5.82	CHEMBL4924	Homo sapiens	Inhibition	%	5.82
	8137224	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	0.53	CHEMBL4924	Homo sapiens	Inhibition	%	0.53
	8137568	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.47	CHEMBL4924	Homo sapiens	Inhibition	%	0.47
	8137716	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	1.38	CHEMBL4924	Homo sapiens	Inhibition	%	1.38
	8138106	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.41	CHEMBL4924	Homo sapiens	Inhibition	%	0.41
	8138285	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.32	CHEMBL4924	Homo sapiens	Inhibition	%	0.32
	8138657	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-0.44	CHEMBL4924	Homo sapiens	Inhibition	%	-0.44
	8138815	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	-0.14	CHEMBL4924	Homo sapiens	Inhibition	%	-0.14
	8139224	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	1.37	CHEMBL4924	Homo sapiens	Inhibition	%	1.37
	8139383	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	1.31	CHEMBL4924	Homo sapiens	Inhibition	%	1.31
	8139721	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.75	CHEMBL4924	Homo sapiens	Inhibition	%	0.75
	8139862	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.65	CHEMBL4924	Homo sapiens	Inhibition	%	1.65
	8140086	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	1.89	CHEMBL4924	Homo sapiens	Inhibition	%	1.89
	8140209	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	-0.07	CHEMBL4924	Homo sapiens	Inhibition	%	-0.07
	8140592	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	0.1	CHEMBL4924	Homo sapiens	Inhibition	%	0.1
	8140735	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	3.03	CHEMBL4924	Homo sapiens	Inhibition	%	3.03
	8141037	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	1.57	CHEMBL4924	Homo sapiens	Inhibition	%	1.57
	8141391	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.59	CHEMBL4924	Homo sapiens	Inhibition	%	0.59
	8141551	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	3.54	CHEMBL4924	Homo sapiens	Inhibition	%	3.54
	8141894	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	0.69	CHEMBL4924	Homo sapiens	Inhibition	%	0.69
	8142055	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	0.7	CHEMBL4924	Homo sapiens	Inhibition	%	0.7
	8142279	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	2.56	CHEMBL4924	Homo sapiens	Inhibition	%	2.56
	8142447	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	13.2	CHEMBL4924	Homo sapiens	Inhibition	%	13.2
	8142623	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	0.37	CHEMBL4924	Homo sapiens	Inhibition	%	0.37
	8142847	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	0.98	CHEMBL4924	Homo sapiens	Inhibition	%	0.98
	8142996	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	0.59	CHEMBL4924	Homo sapiens	Inhibition	%	0.59
	8143151	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.9	CHEMBL4924	Homo sapiens	Inhibition	%	0.9
	8143375	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	0.51	CHEMBL4924	Homo sapiens	Inhibition	%	0.51
	8143562	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.84	CHEMBL4924	Homo sapiens	Inhibition	%	3.84
	8143721	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	0.82	CHEMBL4924	Homo sapiens	Inhibition	%	0.82
	8143945	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	2.56	CHEMBL4924	Homo sapiens	Inhibition	%	2.56
	8144059	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-0.12	CHEMBL4924	Homo sapiens	Inhibition	%	-0.12
	8144422	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.79	CHEMBL4924	Homo sapiens	Inhibition	%	0.79
	8144552	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	1.86	CHEMBL4924	Homo sapiens	Inhibition	%	1.86
	8144929	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	1.28	CHEMBL4924	Homo sapiens	Inhibition	%	1.28
	8145066	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	0.95	CHEMBL4924	Homo sapiens	Inhibition	%	0.95
	8145290	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.81	CHEMBL4924	Homo sapiens	Inhibition	%	1.81
	8145379	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	0.95	CHEMBL4924	Homo sapiens	Inhibition	%	0.95
	8145727	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	0.71	CHEMBL4924	Homo sapiens	Inhibition	%	0.71
	8145888	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	0.45	CHEMBL4924	Homo sapiens	Inhibition	%	0.45
	8146112	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	1.06	CHEMBL4924	Homo sapiens	Inhibition	%	1.06
	8146232	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	48.56	CHEMBL4924	Homo sapiens	Inhibition	%	48.56
	8146616	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	0.38	CHEMBL4924	Homo sapiens	Inhibition	%	0.38
	8146783	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	54.92	CHEMBL4924	Homo sapiens	Inhibition	%	54.92
	8147176	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	9.62	CHEMBL4924	Homo sapiens	Inhibition	%	9.62
	8147318	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	1.3	CHEMBL4924	Homo sapiens	Inhibition	%	1.3
	8147695	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.81	CHEMBL4924	Homo sapiens	Inhibition	%	0.81
	8147882	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	2.52	CHEMBL4924	Homo sapiens	Inhibition	%	2.52
	8148264	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	2.12	CHEMBL4924	Homo sapiens	Inhibition	%	2.12
	8148378	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-1.41	CHEMBL4924	Homo sapiens	Inhibition	%	-1.41
	8148602	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-1.99	CHEMBL4924	Homo sapiens	Inhibition	%	-1.99
	8148741	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	0.57	CHEMBL4924	Homo sapiens	Inhibition	%	0.57
	8148879	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	1.77	CHEMBL4924	Homo sapiens	Inhibition	%	1.77
	8149103	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	3.24	CHEMBL4924	Homo sapiens	Inhibition	%	3.24
	8149262	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.25	CHEMBL4924	Homo sapiens	Inhibition	%	-0.25
	8149620	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	9.72	CHEMBL4924	Homo sapiens	Inhibition	%	9.72
	8149718	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	1.15	CHEMBL4924	Homo sapiens	Inhibition	%	1.15
	8149942	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	2.66	CHEMBL4924	Homo sapiens	Inhibition	%	2.66
	8150067	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.96	CHEMBL4924	Homo sapiens	Inhibition	%	0.96
	8150451	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	-0.53	CHEMBL4924	Homo sapiens	Inhibition	%	-0.53
	8150571	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	0.24	CHEMBL4924	Homo sapiens	Inhibition	%	0.24
	8150795	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.53	CHEMBL4924	Homo sapiens	Inhibition	%	0.53
	8150960	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	16.38	CHEMBL4924	Homo sapiens	Inhibition	%	16.38
	8151123	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.73	CHEMBL4924	Homo sapiens	Inhibition	%	-0.73
	8151347	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-0.57	CHEMBL4924	Homo sapiens	Inhibition	%	-0.57
	8151524	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.44	CHEMBL4924	Homo sapiens	Inhibition	%	1.44
	8151662	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	0.82	CHEMBL4924	Homo sapiens	Inhibition	%	0.82
	8151886	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.47	CHEMBL4924	Homo sapiens	Inhibition	%	-0.47
	8152040	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	0.26	CHEMBL4924	Homo sapiens	Inhibition	%	0.26
	8152228	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.3	CHEMBL4924	Homo sapiens	Inhibition	%	7.3
	8152610	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	3.23	CHEMBL4924	Homo sapiens	Inhibition	%	3.23
	8152948	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	-0.55	CHEMBL4924	Homo sapiens	Inhibition	%	-0.55
	8153087	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.22	CHEMBL4924	Homo sapiens	Inhibition	%	1.22
	8153448	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	1.32	CHEMBL4924	Homo sapiens	Inhibition	%	1.32
	8153605	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-0.88	CHEMBL4924	Homo sapiens	Inhibition	%	-0.88
	8153962	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	37.3	CHEMBL4924	Homo sapiens	Inhibition	%	37.3
	8154283	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	1.71	CHEMBL4924	Homo sapiens	Inhibition	%	1.71
	8154409	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	3.95	CHEMBL4924	Homo sapiens	Inhibition	%	3.95
	8154633	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.35	CHEMBL4924	Homo sapiens	Inhibition	%	1.35
	8154792	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.05	CHEMBL4924	Homo sapiens	Inhibition	%	0.05
	8155136	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	0.2	CHEMBL4924	Homo sapiens	Inhibition	%	0.2
	8155312	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	-1.83	CHEMBL4924	Homo sapiens	Inhibition	%	-1.83
	8155697	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	3.57	CHEMBL4924	Homo sapiens	Inhibition	%	3.57
	8155875	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	1.93	CHEMBL4924	Homo sapiens	Inhibition	%	1.93
	8156237	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.99	CHEMBL4924	Homo sapiens	Inhibition	%	-0.99
	8156449	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	0.9	CHEMBL4924	Homo sapiens	Inhibition	%	0.9
	8156599	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	2.13	CHEMBL4924	Homo sapiens	Inhibition	%	2.13
	8156823	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	1.79	CHEMBL4924	Homo sapiens	Inhibition	%	1.79
	8156966	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.32	CHEMBL4924	Homo sapiens	Inhibition	%	4.32
	8157310	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	18.91	CHEMBL4924	Homo sapiens	Inhibition	%	18.91
	8157451	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	5.57	CHEMBL4924	Homo sapiens	Inhibition	%	5.57
	8157805	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	2.45	CHEMBL4924	Homo sapiens	Inhibition	%	2.45
	8157966	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	-0.61	CHEMBL4924	Homo sapiens	Inhibition	%	-0.61
	8158190	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	1.31	CHEMBL4924	Homo sapiens	Inhibition	%	1.31
	8158440	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	6.13	CHEMBL4924	Homo sapiens	Inhibition	%	6.13
	8158598	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	4.24	CHEMBL4924	Homo sapiens	Inhibition	%	4.24
	8158991	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.43	CHEMBL4924	Homo sapiens	Inhibition	%	2.43
	8159126	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	2.22	CHEMBL4924	Homo sapiens	Inhibition	%	2.22
	8159470	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	1.3	CHEMBL4924	Homo sapiens	Inhibition	%	1.3
	8159825	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	19.67	CHEMBL4924	Homo sapiens	Inhibition	%	19.67
	8159966	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.77	CHEMBL4924	Homo sapiens	Inhibition	%	0.77
	8160327	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.35	CHEMBL4924	Homo sapiens	Inhibition	%	1.35
	8160477	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.21	CHEMBL4924	Homo sapiens	Inhibition	%	-0.21
	8160771	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	2.4	CHEMBL4924	Homo sapiens	Inhibition	%	2.4
	8161145	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	2.33	CHEMBL4924	Homo sapiens	Inhibition	%	2.33
	8161288	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	3.28	CHEMBL4924	Homo sapiens	Inhibition	%	3.28
	8161637	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	0.75	CHEMBL4924	Homo sapiens	Inhibition	%	0.75
	8161775	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	29.06	CHEMBL4924	Homo sapiens	Inhibition	%	29.06
	8161999	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	1.89	CHEMBL4924	Homo sapiens	Inhibition	%	1.89
	8162129	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	11.1	CHEMBL4924	Homo sapiens	Inhibition	%	11.1
	8162513	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	-0.1	CHEMBL4924	Homo sapiens	Inhibition	%	-0.1
	8162766	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	25.03	CHEMBL4924	Homo sapiens	Inhibition	%	25.03
	8162914	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	29.27	CHEMBL4924	Homo sapiens	Inhibition	%	29.27
	8163138	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	77.37	CHEMBL4924	Homo sapiens	Inhibition	%	77.37
	8163307	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.14	CHEMBL4924	Homo sapiens	Inhibition	%	1.14
	8163441	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	1.82	CHEMBL4924	Homo sapiens	Inhibition	%	1.82
	8163665	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	1.56	CHEMBL4924	Homo sapiens	Inhibition	%	1.56
	8163788	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	2.25	CHEMBL4924	Homo sapiens	Inhibition	%	2.25
	8164146	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	54.1	CHEMBL4924	Homo sapiens	Inhibition	%	54.1
	8164286	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.66	CHEMBL4924	Homo sapiens	Inhibition	%	0.66
	8164510	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	0.95	CHEMBL4924	Homo sapiens	Inhibition	%	0.95
	8164665	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	1.51	CHEMBL4924	Homo sapiens	Inhibition	%	1.51
	8164809	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	3.39	CHEMBL4924	Homo sapiens	Inhibition	%	3.39
	8165033	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	1.37	CHEMBL4924	Homo sapiens	Inhibition	%	1.37
	8165103	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	3.92	CHEMBL4924	Homo sapiens	Inhibition	%	3.92
	8165468	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.39	CHEMBL4924	Homo sapiens	Inhibition	%	0.39
	8165611	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	9.17	CHEMBL4924	Homo sapiens	Inhibition	%	9.17
	8165835	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	0.65	CHEMBL4924	Homo sapiens	Inhibition	%	0.65
	8165961	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	7.12	CHEMBL4924	Homo sapiens	Inhibition	%	7.12
	8166323	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	4.03	CHEMBL4924	Homo sapiens	Inhibition	%	4.03
	8166453	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.27	CHEMBL4924	Homo sapiens	Inhibition	%	2.27
	8166677	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	2.67	CHEMBL4924	Homo sapiens	Inhibition	%	2.67
	8166778	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	2.74	CHEMBL4924	Homo sapiens	Inhibition	%	2.74
	8167090	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	2.18	CHEMBL4924	Homo sapiens	Inhibition	%	2.18
	8167455	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	11.48	CHEMBL4924	Homo sapiens	Inhibition	%	11.48
	8167619	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	1.27	CHEMBL4924	Homo sapiens	Inhibition	%	1.27
	8167976	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.11	CHEMBL4924	Homo sapiens	Inhibition	%	3.11
	8168100	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.07	CHEMBL4924	Homo sapiens	Inhibition	%	2.07
	8168324	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.82	CHEMBL4924	Homo sapiens	Inhibition	%	2.82
	8168465	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.24	CHEMBL4924	Homo sapiens	Inhibition	%	2.24
	8168825	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-0.55	CHEMBL4924	Homo sapiens	Inhibition	%	-0.55
	8168989	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.8	CHEMBL4924	Homo sapiens	Inhibition	%	8.8
	8169355	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.46	CHEMBL4924	Homo sapiens	Inhibition	%	3.46
	8169435	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	19.66	CHEMBL4924	Homo sapiens	Inhibition	%	19.66
	8169659	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	4.08	CHEMBL4924	Homo sapiens	Inhibition	%	4.08
	8169793	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	0.63	CHEMBL4924	Homo sapiens	Inhibition	%	0.63
	8170162	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	5.35	CHEMBL4924	Homo sapiens	Inhibition	%	5.35
	8170287	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	1.43	CHEMBL4924	Homo sapiens	Inhibition	%	1.43
	8170511	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	2.27	CHEMBL4924	Homo sapiens	Inhibition	%	2.27
	8170651	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	2.29	CHEMBL4924	Homo sapiens	Inhibition	%	2.29
	8171010	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	-0.42	CHEMBL4924	Homo sapiens	Inhibition	%	-0.42
	8171207	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	1.26	CHEMBL4924	Homo sapiens	Inhibition	%	1.26
	8171424	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	13.85	CHEMBL4924	Homo sapiens	Inhibition	%	13.85
	8171789	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	49.58	CHEMBL4924	Homo sapiens	Inhibition	%	49.58
	8171942	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	1.48	CHEMBL4924	Homo sapiens	Inhibition	%	1.48
	8172298	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	2.19	CHEMBL4924	Homo sapiens	Inhibition	%	2.19
	8172650	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.75	CHEMBL4924	Homo sapiens	Inhibition	%	0.75
	8172792	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	2.84	CHEMBL4924	Homo sapiens	Inhibition	%	2.84
	8173152	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	0.54	CHEMBL4924	Homo sapiens	Inhibition	%	0.54
	8173317	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	2.25	CHEMBL4924	Homo sapiens	Inhibition	%	2.25
	8173682	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	1.69	CHEMBL4924	Homo sapiens	Inhibition	%	1.69
	8173993	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	22.17	CHEMBL4924	Homo sapiens	Inhibition	%	22.17
	8174125	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	1.66	CHEMBL4924	Homo sapiens	Inhibition	%	1.66
	8174349	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.87	CHEMBL4924	Homo sapiens	Inhibition	%	6.87
	8174497	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.55	CHEMBL4924	Homo sapiens	Inhibition	%	0.55
	8174843	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	1.4	CHEMBL4924	Homo sapiens	Inhibition	%	1.4
	8174986	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	7.82	CHEMBL4924	Homo sapiens	Inhibition	%	7.82
	8175346	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	1.84	CHEMBL4924	Homo sapiens	Inhibition	%	1.84
	8175602	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	11.43	CHEMBL4924	Homo sapiens	Inhibition	%	11.43
	8175765	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	2.03	CHEMBL4924	Homo sapiens	Inhibition	%	2.03
	8175989	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	6.01	CHEMBL4924	Homo sapiens	Inhibition	%	6.01
	8176142	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	10.03	CHEMBL4924	Homo sapiens	Inhibition	%	10.03
	8176291	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	3.07	CHEMBL4924	Homo sapiens	Inhibition	%	3.07
	8176515	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	4.28	CHEMBL4924	Homo sapiens	Inhibition	%	4.28
	8176647	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	16.27	CHEMBL4924	Homo sapiens	Inhibition	%	16.27
	8177001	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	1.74	CHEMBL4924	Homo sapiens	Inhibition	%	1.74
	8177143	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	2.1	CHEMBL4924	Homo sapiens	Inhibition	%	2.1
	8177367	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	0.92	CHEMBL4924	Homo sapiens	Inhibition	%	0.92
	8177505	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	58.23	CHEMBL4924	Homo sapiens	Inhibition	%	58.23
	8177669	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	4.33	CHEMBL4924	Homo sapiens	Inhibition	%	4.33
	8177893	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	1.18	CHEMBL4924	Homo sapiens	Inhibition	%	1.18
	8178033	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	5.51	CHEMBL4924	Homo sapiens	Inhibition	%	5.51
	8178345	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	0.96	CHEMBL4924	Homo sapiens	Inhibition	%	0.96
	8178696	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.4	CHEMBL4924	Homo sapiens	Inhibition	%	1.4
	8178845	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	0.61	CHEMBL4924	Homo sapiens	Inhibition	%	0.61
	8179192	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	2.88	CHEMBL4924	Homo sapiens	Inhibition	%	2.88
	8179336	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.7	CHEMBL4924	Homo sapiens	Inhibition	%	3.7
	8179560	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	11.34	CHEMBL4924	Homo sapiens	Inhibition	%	11.34
	8179697	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	1.43	CHEMBL4924	Homo sapiens	Inhibition	%	1.43
	8179954	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	0.86	CHEMBL4924	Homo sapiens	Inhibition	%	0.86
	8180332	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	1.15	CHEMBL4924	Homo sapiens	Inhibition	%	1.15
	8180488	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	36.23	CHEMBL4924	Homo sapiens	Inhibition	%	36.23
	8180860	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	20.92	CHEMBL4924	Homo sapiens	Inhibition	%	20.92
	8180993	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	2.13	CHEMBL4924	Homo sapiens	Inhibition	%	2.13
	8181217	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	1.9	CHEMBL4924	Homo sapiens	Inhibition	%	1.9
	8181348	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	2.94	CHEMBL4924	Homo sapiens	Inhibition	%	2.94
	8181712	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.0	CHEMBL4924	Homo sapiens	Inhibition	%	3.0
	8181851	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	88.0	CHEMBL4924	Homo sapiens	Inhibition	%	88.0
	8182238	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	3.36	CHEMBL4924	Homo sapiens	Inhibition	%	3.36
	8182378	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	1.29	CHEMBL4924	Homo sapiens	Inhibition	%	1.29
	8182602	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	0.66	CHEMBL4924	Homo sapiens	Inhibition	%	0.66
	8182694	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	1.62	CHEMBL4924	Homo sapiens	Inhibition	%	1.62
	8183040	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	1.84	CHEMBL4924	Homo sapiens	Inhibition	%	1.84
	8183189	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	-0.11	CHEMBL4924	Homo sapiens	Inhibition	%	-0.11
	8183413	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	3.54	CHEMBL4924	Homo sapiens	Inhibition	%	3.54
	8183542	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	-0.08	CHEMBL4924	Homo sapiens	Inhibition	%	-0.08
	8183908	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	0.98	CHEMBL4924	Homo sapiens	Inhibition	%	0.98
	8184044	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	0.41	CHEMBL4924	Homo sapiens	Inhibition	%	0.41
	8184310	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	1.86	CHEMBL4924	Homo sapiens	Inhibition	%	1.86
	8184681	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	2.27	CHEMBL4924	Homo sapiens	Inhibition	%	2.27
	8184838	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	2.06	CHEMBL4924	Homo sapiens	Inhibition	%	2.06
	8185062	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	5.49	CHEMBL4924	Homo sapiens	Inhibition	%	5.49
	8185211	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.19	CHEMBL4924	Homo sapiens	Inhibition	%	0.19
	8185566	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	1.75	CHEMBL4924	Homo sapiens	Inhibition	%	1.75
	8185697	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	20.68	CHEMBL4924	Homo sapiens	Inhibition	%	20.68
	8186060	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	3.11	CHEMBL4924	Homo sapiens	Inhibition	%	3.11
	8186201	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.78	CHEMBL4924	Homo sapiens	Inhibition	%	1.78
	8186425	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	1.98	CHEMBL4924	Homo sapiens	Inhibition	%	1.98
	8186589	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	2.62	CHEMBL4924	Homo sapiens	Inhibition	%	2.62
	8186952	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	1.56	CHEMBL4924	Homo sapiens	Inhibition	%	1.56
	8187050	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	0.72	CHEMBL4924	Homo sapiens	Inhibition	%	0.72
	8187274	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	1.18	CHEMBL4924	Homo sapiens	Inhibition	%	1.18
	8187398	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8187770	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	0.65	CHEMBL4924	Homo sapiens	Inhibition	%	0.65
	8187899	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	0.72	CHEMBL4924	Homo sapiens	Inhibition	%	0.72
	8188266	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	3.15	CHEMBL4924	Homo sapiens	Inhibition	%	3.15
	8188401	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	0.99	CHEMBL4924	Homo sapiens	Inhibition	%	0.99
	8188625	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	3.2	CHEMBL4924	Homo sapiens	Inhibition	%	3.2
	8188675	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	1.16	CHEMBL4924	Homo sapiens	Inhibition	%	1.16
	8188899	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.99	CHEMBL4924	Homo sapiens	Inhibition	%	4.99
	8189047	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	1.4	CHEMBL4924	Homo sapiens	Inhibition	%	1.4
	8189427	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.77	CHEMBL4924	Homo sapiens	Inhibition	%	4.77
	8189576	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	1.01	CHEMBL4924	Homo sapiens	Inhibition	%	1.01
	8189932	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	3.55	CHEMBL4924	Homo sapiens	Inhibition	%	3.55
	8190064	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	-0.23	CHEMBL4924	Homo sapiens	Inhibition	%	-0.23
	8190288	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	2.05	CHEMBL4924	Homo sapiens	Inhibition	%	2.05
	8190428	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.79	CHEMBL4924	Homo sapiens	Inhibition	%	2.79
	8190789	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.56	CHEMBL4924	Homo sapiens	Inhibition	%	1.56
	8190953	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	4.12	CHEMBL4924	Homo sapiens	Inhibition	%	4.12
	8191315	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	3.59	CHEMBL4924	Homo sapiens	Inhibition	%	3.59
	8191635	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.55	CHEMBL4924	Homo sapiens	Inhibition	%	0.55
	8191757	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	3.03	CHEMBL4924	Homo sapiens	Inhibition	%	3.03
	8192130	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	1.72	CHEMBL4924	Homo sapiens	Inhibition	%	1.72
	8192259	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.98	CHEMBL4924	Homo sapiens	Inhibition	%	0.98
	8192483	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	0.1	CHEMBL4924	Homo sapiens	Inhibition	%	0.1
	8192627	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.45	CHEMBL4924	Homo sapiens	Inhibition	%	0.45
	8192987	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	1.36	CHEMBL4924	Homo sapiens	Inhibition	%	1.36
	8193259	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.55	CHEMBL4924	Homo sapiens	Inhibition	%	0.55
	8193404	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.17	CHEMBL4924	Homo sapiens	Inhibition	%	3.17
	8193628	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	2.26	CHEMBL4924	Homo sapiens	Inhibition	%	2.26
	8193785	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	22.41	CHEMBL4924	Homo sapiens	Inhibition	%	22.41
	8193934	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.21	CHEMBL4924	Homo sapiens	Inhibition	%	-0.21
	8194158	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-0.13	CHEMBL4924	Homo sapiens	Inhibition	%	-0.13
	8194289	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	2.48	CHEMBL4924	Homo sapiens	Inhibition	%	2.48
	8194644	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	2.11	CHEMBL4924	Homo sapiens	Inhibition	%	2.11
	8194787	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	2.63	CHEMBL4924	Homo sapiens	Inhibition	%	2.63
	8195144	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	1.96	CHEMBL4924	Homo sapiens	Inhibition	%	1.96
	8195308	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	1.47	CHEMBL4924	Homo sapiens	Inhibition	%	1.47
	8195532	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	12.0	CHEMBL4924	Homo sapiens	Inhibition	%	12.0
	8195671	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8195993	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	0.46	CHEMBL4924	Homo sapiens	Inhibition	%	0.46
	8196110	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.96	CHEMBL4924	Homo sapiens	Inhibition	%	0.96
	8196334	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	0.98	CHEMBL4924	Homo sapiens	Inhibition	%	0.98
	8196484	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	0.84	CHEMBL4924	Homo sapiens	Inhibition	%	0.84
	8196836	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8196977	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	0.63	CHEMBL4924	Homo sapiens	Inhibition	%	0.63
	8197201	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	-0.43	CHEMBL4924	Homo sapiens	Inhibition	%	-0.43
	8197338	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	0.36	CHEMBL4924	Homo sapiens	Inhibition	%	0.36
	8197613	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	0.89	CHEMBL4924	Homo sapiens	Inhibition	%	0.89
	8197977	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	17.18	CHEMBL4924	Homo sapiens	Inhibition	%	17.18
	8198134	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.72	CHEMBL4924	Homo sapiens	Inhibition	%	2.72
	8198496	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	-0.68	CHEMBL4924	Homo sapiens	Inhibition	%	-0.68
	8198626	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	3.03	CHEMBL4924	Homo sapiens	Inhibition	%	3.03
	8198981	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	1.19	CHEMBL4924	Homo sapiens	Inhibition	%	1.19
	8199129	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	2.02	CHEMBL4924	Homo sapiens	Inhibition	%	2.02
	8199353	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	3.9	CHEMBL4924	Homo sapiens	Inhibition	%	3.9
	8199487	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.21	CHEMBL4924	Homo sapiens	Inhibition	%	1.21
	8199874	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	0.33	CHEMBL4924	Homo sapiens	Inhibition	%	0.33
	8200012	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	2.9	CHEMBL4924	Homo sapiens	Inhibition	%	2.9
	8200340	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	0.64	CHEMBL4924	Homo sapiens	Inhibition	%	0.64
	8200679	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	2.97	CHEMBL4924	Homo sapiens	Inhibition	%	2.97
	8200829	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	4.74	CHEMBL4924	Homo sapiens	Inhibition	%	4.74
	8201053	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	0.29	CHEMBL4924	Homo sapiens	Inhibition	%	0.29
	8201183	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	9.08	CHEMBL4924	Homo sapiens	Inhibition	%	9.08
	8201542	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	0.34	CHEMBL4924	Homo sapiens	Inhibition	%	0.34
	8201675	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	-0.13	CHEMBL4924	Homo sapiens	Inhibition	%	-0.13
	8201954	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	1.6	CHEMBL4924	Homo sapiens	Inhibition	%	1.6
	8202318	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-0.07	CHEMBL4924	Homo sapiens	Inhibition	%	-0.07
	8202485	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	3.9	CHEMBL4924	Homo sapiens	Inhibition	%	3.9
	8202834	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	0.89	CHEMBL4924	Homo sapiens	Inhibition	%	0.89
	8202964	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	1.85	CHEMBL4924	Homo sapiens	Inhibition	%	1.85
	8203188	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.47	CHEMBL4924	Homo sapiens	Inhibition	%	9.47
	8203319	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	2.42	CHEMBL4924	Homo sapiens	Inhibition	%	2.42
	8203689	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	-0.14	CHEMBL4924	Homo sapiens	Inhibition	%	-0.14
	8203823	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	1.91	CHEMBL4924	Homo sapiens	Inhibition	%	1.91
	8204047	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8204213	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	1.11	CHEMBL4924	Homo sapiens	Inhibition	%	1.11
	8204350	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	0.21	CHEMBL4924	Homo sapiens	Inhibition	%	0.21
	8204574	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	1.1	CHEMBL4924	Homo sapiens	Inhibition	%	1.1
	8204679	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	1.59	CHEMBL4924	Homo sapiens	Inhibition	%	1.59
	8205018	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	13.29	CHEMBL4924	Homo sapiens	Inhibition	%	13.29
	8205391	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	10.47	CHEMBL4924	Homo sapiens	Inhibition	%	10.47
	8205527	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	1.8	CHEMBL4924	Homo sapiens	Inhibition	%	1.8
	8205890	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.16	CHEMBL4924	Homo sapiens	Inhibition	%	1.16
	8206022	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.61	CHEMBL4924	Homo sapiens	Inhibition	%	0.61
	8206246	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-1.6	CHEMBL4924	Homo sapiens	Inhibition	%	-1.6
	8206298	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	0.81	CHEMBL4924	Homo sapiens	Inhibition	%	0.81
	8206522	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	1.59	CHEMBL4924	Homo sapiens	Inhibition	%	1.59
	8206665	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	2.87	CHEMBL4924	Homo sapiens	Inhibition	%	2.87
	8206845	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	1.79	CHEMBL4924	Homo sapiens	Inhibition	%	1.79
	8207069	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.47	CHEMBL4924	Homo sapiens	Inhibition	%	4.47
	8207195	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	1.97	CHEMBL4924	Homo sapiens	Inhibition	%	1.97
	8207549	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	16.35	CHEMBL4924	Homo sapiens	Inhibition	%	16.35
	8207681	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	4.77	CHEMBL4924	Homo sapiens	Inhibition	%	4.77
	8207905	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	2.55	CHEMBL4924	Homo sapiens	Inhibition	%	2.55
	8208050	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	0.49	CHEMBL4924	Homo sapiens	Inhibition	%	0.49
	8208406	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	1.8	CHEMBL4924	Homo sapiens	Inhibition	%	1.8
	8208572	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	1.04	CHEMBL4924	Homo sapiens	Inhibition	%	1.04
	8208929	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	10.33	CHEMBL4924	Homo sapiens	Inhibition	%	10.33
	8209034	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	-0.01	CHEMBL4924	Homo sapiens	Inhibition	%	-0.01
	8209258	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	0.75	CHEMBL4924	Homo sapiens	Inhibition	%	0.75
	8209374	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.91	CHEMBL4924	Homo sapiens	Inhibition	%	0.91
	8209748	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	1.52	CHEMBL4924	Homo sapiens	Inhibition	%	1.52
	8209884	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	4.02	CHEMBL4924	Homo sapiens	Inhibition	%	4.02
	8210108	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	3.57	CHEMBL4924	Homo sapiens	Inhibition	%	3.57
	8210249	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	1.0	CHEMBL4924	Homo sapiens	Inhibition	%	1.0
	8210609	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	1.64	CHEMBL4924	Homo sapiens	Inhibition	%	1.64
	8210868	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	2.38	CHEMBL4924	Homo sapiens	Inhibition	%	2.38
	8211012	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.2	CHEMBL4924	Homo sapiens	Inhibition	%	1.2
	8211406	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8211529	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	2.73	CHEMBL4924	Homo sapiens	Inhibition	%	2.73
	8211753	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	2.51	CHEMBL4924	Homo sapiens	Inhibition	%	2.51
	8211882	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	59.73	CHEMBL4924	Homo sapiens	Inhibition	%	59.73
	8212238	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	3.01	CHEMBL4924	Homo sapiens	Inhibition	%	3.01
	8212379	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	1.52	CHEMBL4924	Homo sapiens	Inhibition	%	1.52
	8212736	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.12	CHEMBL4924	Homo sapiens	Inhibition	%	2.12
	8212906	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	7.45	CHEMBL4924	Homo sapiens	Inhibition	%	7.45
	8213130	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.67	CHEMBL4924	Homo sapiens	Inhibition	%	0.67
	8213259	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	39.26	CHEMBL4924	Homo sapiens	Inhibition	%	39.26
	8213587	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.33	CHEMBL4924	Homo sapiens	Inhibition	%	-1.33
	8213700	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	0.55	CHEMBL4924	Homo sapiens	Inhibition	%	0.55
	8213924	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	0.86	CHEMBL4924	Homo sapiens	Inhibition	%	0.86
	8214071	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	3.54	CHEMBL4924	Homo sapiens	Inhibition	%	3.54
	8214432	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	25.53	CHEMBL4924	Homo sapiens	Inhibition	%	25.53
	8214566	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	2.28	CHEMBL4924	Homo sapiens	Inhibition	%	2.28
	8214942	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.33	CHEMBL4924	Homo sapiens	Inhibition	%	-0.33
	8215193	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	2.26	CHEMBL4924	Homo sapiens	Inhibition	%	2.26
	8215346	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	1.66	CHEMBL4924	Homo sapiens	Inhibition	%	1.66
	8215570	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	1.93	CHEMBL4924	Homo sapiens	Inhibition	%	1.93
	8215734	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	2.42	CHEMBL4924	Homo sapiens	Inhibition	%	2.42
	8216077	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	8.27	CHEMBL4924	Homo sapiens	Inhibition	%	8.27
	8216196	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	0.36	CHEMBL4924	Homo sapiens	Inhibition	%	0.36
	8216556	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	7.24	CHEMBL4924	Homo sapiens	Inhibition	%	7.24
	8216694	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.8	CHEMBL4924	Homo sapiens	Inhibition	%	4.8
	8216918	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	11.68	CHEMBL4924	Homo sapiens	Inhibition	%	11.68
	8217052	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	2.8	CHEMBL4924	Homo sapiens	Inhibition	%	2.8
	8217450	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	0.25	CHEMBL4924	Homo sapiens	Inhibition	%	0.25
	8217581	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	3.14	CHEMBL4924	Homo sapiens	Inhibition	%	3.14
	8217906	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.03	CHEMBL4924	Homo sapiens	Inhibition	%	-1.03
	8218245	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	2.06	CHEMBL4924	Homo sapiens	Inhibition	%	2.06
	8218372	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	2.38	CHEMBL4924	Homo sapiens	Inhibition	%	2.38
	8218739	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	0.74	CHEMBL4924	Homo sapiens	Inhibition	%	0.74
	8218870	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	7.33	CHEMBL4924	Homo sapiens	Inhibition	%	7.33
	8219094	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	1.69	CHEMBL4924	Homo sapiens	Inhibition	%	1.69
	8219254	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	-0.39	CHEMBL4924	Homo sapiens	Inhibition	%	-0.39
	8219504	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.56	CHEMBL4924	Homo sapiens	Inhibition	%	3.56
	8219889	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	2.17	CHEMBL4924	Homo sapiens	Inhibition	%	2.17
	8220058	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.09	CHEMBL4924	Homo sapiens	Inhibition	%	2.09
	8220411	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	2.36	CHEMBL4924	Homo sapiens	Inhibition	%	2.36
	8220525	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.19	CHEMBL4924	Homo sapiens	Inhibition	%	2.19
	8220749	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	7.7	CHEMBL4924	Homo sapiens	Inhibition	%	7.7
	8220887	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	37.64	CHEMBL4924	Homo sapiens	Inhibition	%	37.64
	8221247	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	40.69	CHEMBL4924	Homo sapiens	Inhibition	%	40.69
	8221380	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	2.17	CHEMBL4924	Homo sapiens	Inhibition	%	2.17
	8221769	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.34	CHEMBL4924	Homo sapiens	Inhibition	%	0.34
	8221900	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	16.41	CHEMBL4924	Homo sapiens	Inhibition	%	16.41
	8222124	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	0.59	CHEMBL4924	Homo sapiens	Inhibition	%	0.59
	8222222	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	1.0	CHEMBL4924	Homo sapiens	Inhibition	%	1.0
	8222580	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	1.15	CHEMBL4924	Homo sapiens	Inhibition	%	1.15
	8222698	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	6.67	CHEMBL4924	Homo sapiens	Inhibition	%	6.67
	8222922	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	3.48	CHEMBL4924	Homo sapiens	Inhibition	%	3.48
	8223066	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	17.42	CHEMBL4924	Homo sapiens	Inhibition	%	17.42
	8223419	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	2.72	CHEMBL4924	Homo sapiens	Inhibition	%	2.72
	8223580	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	0.69	CHEMBL4924	Homo sapiens	Inhibition	%	0.69
	8223830	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	1.53	CHEMBL4924	Homo sapiens	Inhibition	%	1.53
	8224054	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	2.04	CHEMBL4924	Homo sapiens	Inhibition	%	2.04
	8224216	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	2.53	CHEMBL4924	Homo sapiens	Inhibition	%	2.53
	8224386	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	2.65	CHEMBL4924	Homo sapiens	Inhibition	%	2.65
	8224610	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	-0.13	CHEMBL4924	Homo sapiens	Inhibition	%	-0.13
	8224745	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	1.61	CHEMBL4924	Homo sapiens	Inhibition	%	1.61
	8225083	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	36.41	CHEMBL4924	Homo sapiens	Inhibition	%	36.41
	8225217	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	1.24	CHEMBL4924	Homo sapiens	Inhibition	%	1.24
	8225441	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	4.67	CHEMBL4924	Homo sapiens	Inhibition	%	4.67
	8225579	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.28	CHEMBL4924	Homo sapiens	Inhibition	%	1.28
	8225714	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	12.97	CHEMBL4924	Homo sapiens	Inhibition	%	12.97
	8225938	CHEMBL1961934	GSK_PKIS: RSK4 mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	1.4	CHEMBL4924	Homo sapiens	Inhibition	%	1.4
	8226096	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	1.38	CHEMBL4924	Homo sapiens	Inhibition	%	1.38
	8226445	CHEMBL1961935	GSK_PKIS: RSK4 mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	1.0	CHEMBL4924	Homo sapiens	Inhibition	%	1.0
	10839481	CHEMBL2015512	Inhibition of RSK4 N-terminal at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	23.0	CHEMBL4924	Homo sapiens	INH	%	23.0
	10850688	CHEMBL2019861	Inhibition of human RSK4 at 1 uM	B	Cn1cc(-c2cccc(-c3cnc(N)c(C(=O)N[C@H]4C5CC6CC4C[C@@](O)(C6)C5)n3)c2)cn1		CHEMBL2018022	>	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	10981532	CHEMBL2066388	Inhibition of human Rsk4 at 1 uM	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	>=	Inhibition	%	90.0	CHEMBL4924	Homo sapiens	INH	%	90.0
	10981547	CHEMBL2067599	Inhibition of human Rsk4	B	COc1c(Nc2ncc(Cl)c(N[C@H]3[C@@H](C(N)=O)[C@@H]4C=C[C@H]3C4)n2)ccc2c1CC[C@@H](N1CCOCC1)CC2		CHEMBL2064666	=	IC50	nM	19.0	CHEMBL4924	Homo sapiens	IC50	nM	19.0
	12047345	CHEMBL2157698	Inhibition of Rsk4 at 1 uM	B	CC(C)(O)C1CCN(Cc2ccc3nc(-c4c(F)ccc5[nH]ccc45)nc(N4CCOCC4)c3n2)CC1		CHEMBL2152768	=	Inhibition	%	15.2	CHEMBL4924	Homo sapiens	INH	%	15.2
	12068073	CHEMBL2162584	Inhibition of RSK4 at 0.1 uM	B	Cc1nc2cnc3[nH]ccc3c2n1[C@@H]1CCC[C@@H](O)C1		CHEMBL2159210	=	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	12172212	CHEMBL2211992	Inhibition of RSK4 C-terminal domain 2 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	12172213	CHEMBL2211993	Inhibition of RSK4 N-terminal domain 1 assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	71.0	CHEMBL4924	Homo sapiens	Activity	%	71.0
	12259578	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	98.0	CHEMBL4924	Homo sapiens	Residual Activity	%	98.0
	12259579	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	9.0	CHEMBL4924	Homo sapiens	Residual Activity	%	9.0
	12259580	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12259581	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12259582	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12259583	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	106.0	CHEMBL4924	Homo sapiens	Residual Activity	%	106.0
	12259584	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	21.0	CHEMBL4924	Homo sapiens	Residual Activity	%	21.0
	12259585	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	123.0	CHEMBL4924	Homo sapiens	Residual Activity	%	123.0
	12259586	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12259587	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	115.0	CHEMBL4924	Homo sapiens	Residual Activity	%	115.0
	12259588	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	116.0	CHEMBL4924	Homo sapiens	Residual Activity	%	116.0
	12259589	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	108.0	CHEMBL4924	Homo sapiens	Residual Activity	%	108.0
	12259590	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	124.0	CHEMBL4924	Homo sapiens	Residual Activity	%	124.0
	12259591	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	113.0	CHEMBL4924	Homo sapiens	Residual Activity	%	113.0
	12259592	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12259593	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	88.0	CHEMBL4924	Homo sapiens	Residual Activity	%	88.0
	12259594	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12259595	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	97.0	CHEMBL4924	Homo sapiens	Residual Activity	%	97.0
	12259596	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	118.0	CHEMBL4924	Homo sapiens	Residual Activity	%	118.0
	12259597	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	42.0	CHEMBL4924	Homo sapiens	Residual Activity	%	42.0
	12259598	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	109.0	CHEMBL4924	Homo sapiens	Residual Activity	%	109.0
	12259599	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12259600	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	128.0	CHEMBL4924	Homo sapiens	Residual Activity	%	128.0
	12259601	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12259602	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12259603	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12259604	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	26.0	CHEMBL4924	Homo sapiens	Residual Activity	%	26.0
	12259605	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	69.0	CHEMBL4924	Homo sapiens	Residual Activity	%	69.0
	12259606	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	106.0	CHEMBL4924	Homo sapiens	Residual Activity	%	106.0
	12261250	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	5.0	CHEMBL4924	Homo sapiens	Residual Activity	%	5.0
	12261251	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	109.0	CHEMBL4924	Homo sapiens	Residual Activity	%	109.0
	12261252	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	99.0	CHEMBL4924	Homo sapiens	Residual Activity	%	99.0
	12261253	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	106.0	CHEMBL4924	Homo sapiens	Residual Activity	%	106.0
	12261254	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12261255	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12261256	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	114.0	CHEMBL4924	Homo sapiens	Residual Activity	%	114.0
	12261257	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	105.0	CHEMBL4924	Homo sapiens	Residual Activity	%	105.0
	12261258	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	105.0	CHEMBL4924	Homo sapiens	Residual Activity	%	105.0
	12261259	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	113.0	CHEMBL4924	Homo sapiens	Residual Activity	%	113.0
	12261260	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	79.0	CHEMBL4924	Homo sapiens	Residual Activity	%	79.0
	12261261	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	118.0	CHEMBL4924	Homo sapiens	Residual Activity	%	118.0
	12261262	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	128.0	CHEMBL4924	Homo sapiens	Residual Activity	%	128.0
	12261263	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL4924	Homo sapiens	Residual Activity	%	4.0
	12261264	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	10.0	CHEMBL4924	Homo sapiens	Residual Activity	%	10.0
	12261265	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	88.0	CHEMBL4924	Homo sapiens	Residual Activity	%	88.0
	12261266	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12261267	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261268	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	38.0	CHEMBL4924	Homo sapiens	Residual Activity	%	38.0
	12261269	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	96.0	CHEMBL4924	Homo sapiens	Residual Activity	%	96.0
	12261270	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	115.0	CHEMBL4924	Homo sapiens	Residual Activity	%	115.0
	12261271	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	4.0	CHEMBL4924	Homo sapiens	Residual Activity	%	4.0
	12261272	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12261273	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	14.0	CHEMBL4924	Homo sapiens	Residual Activity	%	14.0
	12261274	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	90.0	CHEMBL4924	Homo sapiens	Residual Activity	%	90.0
	12261275	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	123.0	CHEMBL4924	Homo sapiens	Residual Activity	%	123.0
	12261276	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12261277	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	104.0	CHEMBL4924	Homo sapiens	Residual Activity	%	104.0
	12261278	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	114.0	CHEMBL4924	Homo sapiens	Residual Activity	%	114.0
	12261279	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261280	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261281	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	77.0	CHEMBL4924	Homo sapiens	Residual Activity	%	77.0
	12261282	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	0.0	CHEMBL4924	Homo sapiens	Residual Activity	%	0.0
	12261283	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	94.0	CHEMBL4924	Homo sapiens	Residual Activity	%	94.0
	12261284	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261285	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	112.0	CHEMBL4924	Homo sapiens	Residual Activity	%	112.0
	12261286	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12261287	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	113.0	CHEMBL4924	Homo sapiens	Residual Activity	%	113.0
	12261288	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	121.0	CHEMBL4924	Homo sapiens	Residual Activity	%	121.0
	12261289	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12261290	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261291	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	97.0	CHEMBL4924	Homo sapiens	Residual Activity	%	97.0
	12261292	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	96.0	CHEMBL4924	Homo sapiens	Residual Activity	%	96.0
	12261293	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	4.0	CHEMBL4924	Homo sapiens	Residual Activity	%	4.0
	12261294	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	106.0	CHEMBL4924	Homo sapiens	Residual Activity	%	106.0
	12261295	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	72.0	CHEMBL4924	Homo sapiens	Residual Activity	%	72.0
	12261296	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	81.0	CHEMBL4924	Homo sapiens	Residual Activity	%	81.0
	12261297	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	125.0	CHEMBL4924	Homo sapiens	Residual Activity	%	125.0
	12261298	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	14.0	CHEMBL4924	Homo sapiens	Residual Activity	%	14.0
	12261299	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12261300	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	2.0
	12261301	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261302	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	27.0	CHEMBL4924	Homo sapiens	Residual Activity	%	27.0
	12261303	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	83.0	CHEMBL4924	Homo sapiens	Residual Activity	%	83.0
	12261304	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12261305	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	84.0	CHEMBL4924	Homo sapiens	Residual Activity	%	84.0
	12261306	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	104.0	CHEMBL4924	Homo sapiens	Residual Activity	%	104.0
	12261307	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	86.0	CHEMBL4924	Homo sapiens	Residual Activity	%	86.0
	12261308	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	114.0	CHEMBL4924	Homo sapiens	Residual Activity	%	114.0
	12261309	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	96.0	CHEMBL4924	Homo sapiens	Residual Activity	%	96.0
	12261310	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	20.0	CHEMBL4924	Homo sapiens	Residual Activity	%	20.0
	12261311	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	98.0	CHEMBL4924	Homo sapiens	Residual Activity	%	98.0
	12261312	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261313	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	43.0	CHEMBL4924	Homo sapiens	Residual Activity	%	43.0
	12261314	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	96.0	CHEMBL4924	Homo sapiens	Residual Activity	%	96.0
	12261315	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261316	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	85.0	CHEMBL4924	Homo sapiens	Residual Activity	%	85.0
	12261317	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	80.0	CHEMBL4924	Homo sapiens	Residual Activity	%	80.0
	12261318	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	74.0	CHEMBL4924	Homo sapiens	Residual Activity	%	74.0
	12261319	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	72.0	CHEMBL4924	Homo sapiens	Residual Activity	%	72.0
	12261320	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12261321	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	37.0	CHEMBL4924	Homo sapiens	Residual Activity	%	37.0
	12261322	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	-2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	-2.0
	12261323	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12261324	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	9.0	CHEMBL4924	Homo sapiens	Residual Activity	%	9.0
	12261325	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	64.0	CHEMBL4924	Homo sapiens	Residual Activity	%	64.0
	12261326	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	81.0	CHEMBL4924	Homo sapiens	Residual Activity	%	81.0
	12261327	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12261328	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	95.0	CHEMBL4924	Homo sapiens	Residual Activity	%	95.0
	12261329	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261330	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	85.0	CHEMBL4924	Homo sapiens	Residual Activity	%	85.0
	12261331	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12261332	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	81.0	CHEMBL4924	Homo sapiens	Residual Activity	%	81.0
	12261333	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	16.0	CHEMBL4924	Homo sapiens	Residual Activity	%	16.0
	12261334	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	51.0	CHEMBL4924	Homo sapiens	Residual Activity	%	51.0
	12261335	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	27.0	CHEMBL4924	Homo sapiens	Residual Activity	%	27.0
	12261336	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	95.0	CHEMBL4924	Homo sapiens	Residual Activity	%	95.0
	12261337	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	32.0	CHEMBL4924	Homo sapiens	Residual Activity	%	32.0
	12261338	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	108.0	CHEMBL4924	Homo sapiens	Residual Activity	%	108.0
	12261339	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12261340	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12261341	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	86.0	CHEMBL4924	Homo sapiens	Residual Activity	%	86.0
	12261342	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	24.0	CHEMBL4924	Homo sapiens	Residual Activity	%	24.0
	12261343	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	34.0	CHEMBL4924	Homo sapiens	Residual Activity	%	34.0
	12261344	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	97.0	CHEMBL4924	Homo sapiens	Residual Activity	%	97.0
	12261345	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	7.0	CHEMBL4924	Homo sapiens	Residual Activity	%	7.0
	12261346	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	95.0	CHEMBL4924	Homo sapiens	Residual Activity	%	95.0
	12261347	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	40.0	CHEMBL4924	Homo sapiens	Residual Activity	%	40.0
	12261348	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	93.0	CHEMBL4924	Homo sapiens	Residual Activity	%	93.0
	12261349	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12261350	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	-2.0
	12261351	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	84.0	CHEMBL4924	Homo sapiens	Residual Activity	%	84.0
	12261352	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12261353	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	43.0	CHEMBL4924	Homo sapiens	Residual Activity	%	43.0
	12261354	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12261355	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	56.0	CHEMBL4924	Homo sapiens	Residual Activity	%	56.0
	12261356	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	18.0	CHEMBL4924	Homo sapiens	Residual Activity	%	18.0
	12261357	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	83.0	CHEMBL4924	Homo sapiens	Residual Activity	%	83.0
	12261358	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	28.0	CHEMBL4924	Homo sapiens	Residual Activity	%	28.0
	12261359	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	38.0	CHEMBL4924	Homo sapiens	Residual Activity	%	38.0
	12261360	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	59.0	CHEMBL4924	Homo sapiens	Residual Activity	%	59.0
	12261361	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261362	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	18.0	CHEMBL4924	Homo sapiens	Residual Activity	%	18.0
	12261363	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	81.0	CHEMBL4924	Homo sapiens	Residual Activity	%	81.0
	12261364	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	68.0	CHEMBL4924	Homo sapiens	Residual Activity	%	68.0
	12261365	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	90.0	CHEMBL4924	Homo sapiens	Residual Activity	%	90.0
	12261366	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	71.0	CHEMBL4924	Homo sapiens	Residual Activity	%	71.0
	12261367	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	74.0	CHEMBL4924	Homo sapiens	Residual Activity	%	74.0
	12261368	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	63.0	CHEMBL4924	Homo sapiens	Residual Activity	%	63.0
	12261369	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	48.0	CHEMBL4924	Homo sapiens	Residual Activity	%	48.0
	12261370	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12261371	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	53.0	CHEMBL4924	Homo sapiens	Residual Activity	%	53.0
	12261372	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	104.0	CHEMBL4924	Homo sapiens	Residual Activity	%	104.0
	12261373	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	93.0	CHEMBL4924	Homo sapiens	Residual Activity	%	93.0
	12261374	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	83.0	CHEMBL4924	Homo sapiens	Residual Activity	%	83.0
	12261375	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12261376	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	66.0	CHEMBL4924	Homo sapiens	Residual Activity	%	66.0
	12261377	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	88.0	CHEMBL4924	Homo sapiens	Residual Activity	%	88.0
	12261378	CHEMBL2219169	Millipore: Percentage of residual kinase activity of RPS6KA6 at 1uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	97.0	CHEMBL4924	Homo sapiens	Residual Activity	%	97.0
	12261379	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	106.0	CHEMBL4924	Homo sapiens	Residual Activity	%	106.0
	12261380	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	1.0	CHEMBL4924	Homo sapiens	Residual Activity	%	1.0
	12261381	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	99.0	CHEMBL4924	Homo sapiens	Residual Activity	%	99.0
	12261382	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	87.0	CHEMBL4924	Homo sapiens	Residual Activity	%	87.0
	12261383	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	74.0	CHEMBL4924	Homo sapiens	Residual Activity	%	74.0
	12261384	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	98.0	CHEMBL4924	Homo sapiens	Residual Activity	%	98.0
	12261385	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	10.0	CHEMBL4924	Homo sapiens	Residual Activity	%	10.0
	12261386	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	64.0	CHEMBL4924	Homo sapiens	Residual Activity	%	64.0
	12261387	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	84.0	CHEMBL4924	Homo sapiens	Residual Activity	%	84.0
	12261388	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	68.0	CHEMBL4924	Homo sapiens	Residual Activity	%	68.0
	12261389	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	105.0	CHEMBL4924	Homo sapiens	Residual Activity	%	105.0
	12261390	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	80.0	CHEMBL4924	Homo sapiens	Residual Activity	%	80.0
	12261391	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	82.0	CHEMBL4924	Homo sapiens	Residual Activity	%	82.0
	12261392	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	77.0	CHEMBL4924	Homo sapiens	Residual Activity	%	77.0
	12261393	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	30.0	CHEMBL4924	Homo sapiens	Residual Activity	%	30.0
	12261394	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	90.0	CHEMBL4924	Homo sapiens	Residual Activity	%	90.0
	12261395	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	87.0	CHEMBL4924	Homo sapiens	Residual Activity	%	87.0
	12261396	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261397	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	99.0	CHEMBL4924	Homo sapiens	Residual Activity	%	99.0
	12261398	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	37.0	CHEMBL4924	Homo sapiens	Residual Activity	%	37.0
	12261399	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	119.0	CHEMBL4924	Homo sapiens	Residual Activity	%	119.0
	12261400	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12261401	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	94.0	CHEMBL4924	Homo sapiens	Residual Activity	%	94.0
	12261402	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261403	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	120.0	CHEMBL4924	Homo sapiens	Residual Activity	%	120.0
	12261404	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	46.0	CHEMBL4924	Homo sapiens	Residual Activity	%	46.0
	12261405	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	10.0	CHEMBL4924	Homo sapiens	Residual Activity	%	10.0
	12261406	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	18.0	CHEMBL4924	Homo sapiens	Residual Activity	%	18.0
	12261407	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	111.0	CHEMBL4924	Homo sapiens	Residual Activity	%	111.0
	12261408	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	2.0
	12261409	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12261410	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	114.0	CHEMBL4924	Homo sapiens	Residual Activity	%	114.0
	12261411	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	109.0	CHEMBL4924	Homo sapiens	Residual Activity	%	109.0
	12261412	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12261413	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	116.0	CHEMBL4924	Homo sapiens	Residual Activity	%	116.0
	12261414	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12261415	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	87.0	CHEMBL4924	Homo sapiens	Residual Activity	%	87.0
	12261416	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	112.0	CHEMBL4924	Homo sapiens	Residual Activity	%	112.0
	12261417	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	111.0	CHEMBL4924	Homo sapiens	Residual Activity	%	111.0
	12261418	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	113.0	CHEMBL4924	Homo sapiens	Residual Activity	%	113.0
	12261419	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	104.0	CHEMBL4924	Homo sapiens	Residual Activity	%	104.0
	12261420	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261421	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL4924	Homo sapiens	Residual Activity	%	4.0
	12261422	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	1.0	CHEMBL4924	Homo sapiens	Residual Activity	%	1.0
	12261423	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	123.0	CHEMBL4924	Homo sapiens	Residual Activity	%	123.0
	12261424	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	107.0	CHEMBL4924	Homo sapiens	Residual Activity	%	107.0
	12261425	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	130.0	CHEMBL4924	Homo sapiens	Residual Activity	%	130.0
	12261426	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	17.0	CHEMBL4924	Homo sapiens	Residual Activity	%	17.0
	12261427	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	109.0	CHEMBL4924	Homo sapiens	Residual Activity	%	109.0
	12261428	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	110.0	CHEMBL4924	Homo sapiens	Residual Activity	%	110.0
	12261429	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	2.0
	12261430	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	76.0	CHEMBL4924	Homo sapiens	Residual Activity	%	76.0
	12261431	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	2.0
	12261432	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	66.0	CHEMBL4924	Homo sapiens	Residual Activity	%	66.0
	12261433	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	117.0	CHEMBL4924	Homo sapiens	Residual Activity	%	117.0
	12261434	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	136.0	CHEMBL4924	Homo sapiens	Residual Activity	%	136.0
	12261435	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	109.0	CHEMBL4924	Homo sapiens	Residual Activity	%	109.0
	12261436	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12261437	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	62.0	CHEMBL4924	Homo sapiens	Residual Activity	%	62.0
	12261438	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	101.0	CHEMBL4924	Homo sapiens	Residual Activity	%	101.0
	12261439	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	55.0	CHEMBL4924	Homo sapiens	Residual Activity	%	55.0
	12261440	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	3.0	CHEMBL4924	Homo sapiens	Residual Activity	%	3.0
	12261441	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	115.0	CHEMBL4924	Homo sapiens	Residual Activity	%	115.0
	12261442	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	130.0	CHEMBL4924	Homo sapiens	Residual Activity	%	130.0
	12261443	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	121.0	CHEMBL4924	Homo sapiens	Residual Activity	%	121.0
	12261444	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	40.0	CHEMBL4924	Homo sapiens	Residual Activity	%	40.0
	12261445	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12261446	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12261447	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	99.0	CHEMBL4924	Homo sapiens	Residual Activity	%	99.0
	12261448	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	130.0	CHEMBL4924	Homo sapiens	Residual Activity	%	130.0
	12261449	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12261450	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	128.0	CHEMBL4924	Homo sapiens	Residual Activity	%	128.0
	12261451	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	3.0	CHEMBL4924	Homo sapiens	Residual Activity	%	3.0
	12261452	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	133.0	CHEMBL4924	Homo sapiens	Residual Activity	%	133.0
	12261453	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	58.0	CHEMBL4924	Homo sapiens	Residual Activity	%	58.0
	12261454	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	65.0	CHEMBL4924	Homo sapiens	Residual Activity	%	65.0
	12261455	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	103.0	CHEMBL4924	Homo sapiens	Residual Activity	%	103.0
	12261456	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	9.0	CHEMBL4924	Homo sapiens	Residual Activity	%	9.0
	12261457	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	94.0	CHEMBL4924	Homo sapiens	Residual Activity	%	94.0
	12261458	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	0.0	CHEMBL4924	Homo sapiens	Residual Activity	%	0.0
	12261459	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	99.0	CHEMBL4924	Homo sapiens	Residual Activity	%	99.0
	12261460	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	2.0
	12261461	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	82.0	CHEMBL4924	Homo sapiens	Residual Activity	%	82.0
	12261462	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	60.0	CHEMBL4924	Homo sapiens	Residual Activity	%	60.0
	12261463	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12261464	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	96.0	CHEMBL4924	Homo sapiens	Residual Activity	%	96.0
	12261465	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	69.0	CHEMBL4924	Homo sapiens	Residual Activity	%	69.0
	12261466	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	113.0	CHEMBL4924	Homo sapiens	Residual Activity	%	113.0
	12261467	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	87.0	CHEMBL4924	Homo sapiens	Residual Activity	%	87.0
	12261468	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	12.0	CHEMBL4924	Homo sapiens	Residual Activity	%	12.0
	12261469	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	98.0	CHEMBL4924	Homo sapiens	Residual Activity	%	98.0
	12261470	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	88.0	CHEMBL4924	Homo sapiens	Residual Activity	%	88.0
	12261471	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	8.0	CHEMBL4924	Homo sapiens	Residual Activity	%	8.0
	12261472	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	84.0	CHEMBL4924	Homo sapiens	Residual Activity	%	84.0
	12261473	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12261474	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	49.0	CHEMBL4924	Homo sapiens	Residual Activity	%	49.0
	12261475	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	94.0	CHEMBL4924	Homo sapiens	Residual Activity	%	94.0
	12261476	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	112.0	CHEMBL4924	Homo sapiens	Residual Activity	%	112.0
	12261477	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	111.0	CHEMBL4924	Homo sapiens	Residual Activity	%	111.0
	12261478	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	106.0	CHEMBL4924	Homo sapiens	Residual Activity	%	106.0
	12261479	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	36.0	CHEMBL4924	Homo sapiens	Residual Activity	%	36.0
	12261480	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL4924	Homo sapiens	Residual Activity	%	3.0
	12261481	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	133.0	CHEMBL4924	Homo sapiens	Residual Activity	%	133.0
	12261482	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	17.0	CHEMBL4924	Homo sapiens	Residual Activity	%	17.0
	12261483	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	38.0	CHEMBL4924	Homo sapiens	Residual Activity	%	38.0
	12261484	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	91.0	CHEMBL4924	Homo sapiens	Residual Activity	%	91.0
	12263128	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	108.0	CHEMBL4924	Homo sapiens	Residual Activity	%	108.0
	12263129	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	102.0	CHEMBL4924	Homo sapiens	Residual Activity	%	102.0
	12263130	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	95.0	CHEMBL4924	Homo sapiens	Residual Activity	%	95.0
	12263131	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	130.0	CHEMBL4924	Homo sapiens	Residual Activity	%	130.0
	12263132	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	83.0	CHEMBL4924	Homo sapiens	Residual Activity	%	83.0
	12263133	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	117.0	CHEMBL4924	Homo sapiens	Residual Activity	%	117.0
	12263134	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	5.0	CHEMBL4924	Homo sapiens	Residual Activity	%	5.0
	12263135	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	33.0	CHEMBL4924	Homo sapiens	Residual Activity	%	33.0
	12263136	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	29.0	CHEMBL4924	Homo sapiens	Residual Activity	%	29.0
	12263137	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	93.0	CHEMBL4924	Homo sapiens	Residual Activity	%	93.0
	12263138	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	12.0	CHEMBL4924	Homo sapiens	Residual Activity	%	12.0
	12263139	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	90.0	CHEMBL4924	Homo sapiens	Residual Activity	%	90.0
	12263140	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	70.0	CHEMBL4924	Homo sapiens	Residual Activity	%	70.0
	12263141	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12263142	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	84.0	CHEMBL4924	Homo sapiens	Residual Activity	%	84.0
	12263143	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	7.0	CHEMBL4924	Homo sapiens	Residual Activity	%	7.0
	12263144	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	21.0	CHEMBL4924	Homo sapiens	Residual Activity	%	21.0
	12263145	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12263146	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	7.0	CHEMBL4924	Homo sapiens	Residual Activity	%	7.0
	12263147	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	82.0	CHEMBL4924	Homo sapiens	Residual Activity	%	82.0
	12263148	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	24.0	CHEMBL4924	Homo sapiens	Residual Activity	%	24.0
	12263149	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	113.0	CHEMBL4924	Homo sapiens	Residual Activity	%	113.0
	12263150	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	100.0	CHEMBL4924	Homo sapiens	Residual Activity	%	100.0
	12263151	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	-2.0	CHEMBL4924	Homo sapiens	Residual Activity	%	-2.0
	12263152	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	56.0	CHEMBL4924	Homo sapiens	Residual Activity	%	56.0
	12263153	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	95.0	CHEMBL4924	Homo sapiens	Residual Activity	%	95.0
	12263154	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	52.0	CHEMBL4924	Homo sapiens	Residual Activity	%	52.0
	12263155	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	99.0	CHEMBL4924	Homo sapiens	Residual Activity	%	99.0
	12263156	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	41.0	CHEMBL4924	Homo sapiens	Residual Activity	%	41.0
	12263157	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	6.0	CHEMBL4924	Homo sapiens	Residual Activity	%	6.0
	12263158	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	71.0	CHEMBL4924	Homo sapiens	Residual Activity	%	71.0
	12263159	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	7.0	CHEMBL4924	Homo sapiens	Residual Activity	%	7.0
	12263160	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	24.0	CHEMBL4924	Homo sapiens	Residual Activity	%	24.0
	12263161	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	67.0	CHEMBL4924	Homo sapiens	Residual Activity	%	67.0
	12263162	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	104.0	CHEMBL4924	Homo sapiens	Residual Activity	%	104.0
	12263163	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	9.0	CHEMBL4924	Homo sapiens	Residual Activity	%	9.0
	12263164	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	73.0	CHEMBL4924	Homo sapiens	Residual Activity	%	73.0
	12263165	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	63.0	CHEMBL4924	Homo sapiens	Residual Activity	%	63.0
	12263166	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	111.0	CHEMBL4924	Homo sapiens	Residual Activity	%	111.0
	12263167	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	49.0	CHEMBL4924	Homo sapiens	Residual Activity	%	49.0
	12263168	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	89.0	CHEMBL4924	Homo sapiens	Residual Activity	%	89.0
	12263169	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	63.0	CHEMBL4924	Homo sapiens	Residual Activity	%	63.0
	12263170	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	30.0	CHEMBL4924	Homo sapiens	Residual Activity	%	30.0
	12263171	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	90.0	CHEMBL4924	Homo sapiens	Residual Activity	%	90.0
	12263172	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	12.0	CHEMBL4924	Homo sapiens	Residual Activity	%	12.0
	12263173	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	121.0	CHEMBL4924	Homo sapiens	Residual Activity	%	121.0
	12263174	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	96.0	CHEMBL4924	Homo sapiens	Residual Activity	%	96.0
	12263175	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	65.0	CHEMBL4924	Homo sapiens	Residual Activity	%	65.0
	12263176	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	90.0	CHEMBL4924	Homo sapiens	Residual Activity	%	90.0
	12263177	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	77.0	CHEMBL4924	Homo sapiens	Residual Activity	%	77.0
	12263178	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	92.0	CHEMBL4924	Homo sapiens	Residual Activity	%	92.0
	12263179	CHEMBL2219170	Millipore: Percentage of residual kinase activity of RPS6KA6 at 10uM relative to control. Control inhibitor: Staurosporine at 10.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 30 mM NaCl	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	93.0	CHEMBL4924	Homo sapiens	Residual Activity	%	93.0
	12671701	CHEMBL2341951	Binding affinity to RSK4 (unknown origin) at 10 uM relative to control	B	COc1ccc(-c2nc(SCc3ccccc3)nc(N3CCOCC3)c2C#N)cc1		CHEMBL2338504	=	Activity	%	35.0	CHEMBL4924	Homo sapiens	Activity	%	35.0
	12693168	CHEMBL2345770	Inhibition of RSK4 (unknown origin)	B	Cc1c(C(=O)N2CCOc3ccc(-c4ccc(N)nc4)cc3C2)ccc(S(C)(=O)=O)c1F		CHEMBL2333365	>	IC50	nM	10000.0	CHEMBL4924	Homo sapiens	IC50	nM	10000.0
	12727653	CHEMBL2351117	Inhibition of RSK4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	O=c1[nH]c2ncc(-c3ccc(-c4nc[nH]n4)cc3)nc2n1CCC1CCOCC1		CHEMBL2348865	=	Activity	%	94.0	CHEMBL4924	Homo sapiens	Activity	%	94.0
	12728939	CHEMBL2352838	Inhibition of RSK4 (unknown origin) assessed as remaining activity at 1 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	98.0	CHEMBL4924	Homo sapiens	Activity	%	98.0
	12729826	CHEMBL2352158	Inhibition of RSK4 (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	101.0	CHEMBL4924	Homo sapiens	Activity	%	101.0
	12730082	CHEMBL2351117	Inhibition of RSK4 (unknown origin) assessed as remaining activity at 10 uM relative to control	B	CC(C)(O)c1ccc(-c2cnc3c(n2)N(CC2CCOCC2)CC(=O)N3)cn1		CHEMBL2348862	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	13315788	CHEMBL2389252	Inhibition of RSK4 (unknown origin) at 100 x Ki relative to control	B	N#Cc1cc(F)c(C(=O)Nc2ccnc(NC(=O)[C@H]3C[C@H]3F)c2)c(Cl)c1		CHEMBL2387223	>	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	13315801	CHEMBL2389262	Inhibition of RSK4 (unknown origin) at 180 nM relative to control	B	N#Cc1cc(Cl)c(C(=O)Nc2ccnc(NC(=O)C3CC3)c2)c(Cl)c1		CHEMBL2387124	=	Inhibition	%	80.0	CHEMBL4924	Homo sapiens	INH	%	80.0
	13374352	CHEMBL2406297	Inhibition of RSK4 (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	-5.0	CHEMBL4924	Homo sapiens	INH	%	-5.0
	13439753	CHEMBL2428994	Competitive binding affinity to RPS6KA6 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	=	Inhibition	%	84.0	CHEMBL4924	Homo sapiens	INH	%	84.0
	13439754	CHEMBL2428995	Competitive binding affinity to RPS6KA6 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	13442608	CHEMBL2428995	Competitive binding affinity to RPS6KA6 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-c3n[nH]c4ccccc34)n2)CC1		CHEMBL2425644	=	Inhibition	%	79.0	CHEMBL4924	Homo sapiens	INH	%	79.0
	13445586	CHEMBL2428994	Competitive binding affinity to RPS6KA6 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	=	Inhibition	%	100.0	CHEMBL4924	Homo sapiens	INH	%	100.0
	13445587	CHEMBL2428995	Competitive binding affinity to RPS6KA6 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	13451573	CHEMBL2428994	Competitive binding affinity to RPS6KA6 kinase domain 2 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	=	Inhibition	%	100.0	CHEMBL4924	Homo sapiens	INH	%	100.0
	13451574	CHEMBL2428995	Competitive binding affinity to RPS6KA6 kinase domain 1 (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
Active	13475275	CHEMBL2438986	Inhibition of human wild type RSK4 at 1 uM by qPCR analysis	B	CCSCc1ccc2c(c1)c1c3c(c4c5cc(CSCC)ccc5n5c4c1n2[C@H]1C[C@](O)(C(=O)OC)[C@]5(C)O1)CNC3=O		CHEMBL290352		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
Not Active	13475276	CHEMBL2438986	Inhibition of human wild type RSK4 at 1 uM by qPCR analysis	B	CN1CCN(Cc2ccc(-c3cnc4[nH]cc(-c5ccc6[nH]ccc6c5)c4c3)cc2)CC1		CHEMBL2436978		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
	13928580	CHEMBL3124206	Inhibition of RSK4 (unknown origin) at 0.1 uM relative to control	B	CNc1nc(Nc2cn(C(C)(C)C#N)nc2C)ncc1C(F)(F)F		CHEMBL3122113	=	Inhibition	%	62.0	CHEMBL4924	Homo sapiens	INH	%	62.0
	15018693	CHEMBL3369193	Inhibition of RSK4 (unknown origin) at 100 nM	B	O=C(N[C@H](CO)c1ccc(Cl)c(F)c1)N1CCc2cnc(NC3CCOCC3)nc2C1		CHEMBL3298678	=	Inhibition	%	5.8	CHEMBL4924	Homo sapiens	INH	%	5.8
	15055362	CHEMBL3380494	Inhibition of RPS6KA6 (unknown origin) assessed as residual activity at 1 uM by radiometric protein kinase assay	B	COc1cc(-c2c[nH]c(=O)c(-c3cc(OC)c(OC)c(OC)c3)n2)ccc1O		CHEMBL3358999	=	Activity	%	16.0	CHEMBL4924	Homo sapiens	Activity	%	16.0
	15684367	CHEMBL3606280	Binding affinity to DNA-tagged RSK4 N-terminal kinase domain (unknown origin) assessed as level of protein captured on solid support at 10 uM by qPCR analysis relative to control	B	Oc1c(F)cc(-c2cnccc2-c2ccc(N3CCOCC3)cc2)cc1F		CHEMBL3604794	=	Activity	%	0.0	CHEMBL4924	Homo sapiens	Activity	%	0.0
	15756820	CHEMBL3631466	Inhibition of RSK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	4.26	CHEMBL4924	Homo sapiens	INH	%	4.26
	15757903	CHEMBL3631466	Inhibition of RSK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	66.91	CHEMBL4924	Homo sapiens	INH	%	66.91
	15758882	CHEMBL3631466	Inhibition of RSK4 (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	1.08	CHEMBL4924	Homo sapiens	INH	%	1.08
	16431998	CHEMBL3750152	Inhibition of human RSK4 using [KEAKEKRQEQIAKRRRLSLRASTSKSGGSQK] as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4924	Homo sapiens	IC50	uM	10.0
	16451602	CHEMBL3761183	Inhibition of RSK4 (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	9.8	CHEMBL4924	Homo sapiens	INH	%	9.8
	16495218	CHEMBL3777760	Inhibition of N-terminal His6-tagged recombinant human RSK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	3.0	CHEMBL4924	Homo sapiens	Activity	%	3.0
	16496137	CHEMBL3777760	Inhibition of N-terminal His6-tagged recombinant human RSK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-18.0	CHEMBL4924	Homo sapiens	Activity	%	-18.0
	16508927	CHEMBL3777760	Inhibition of N-terminal His6-tagged recombinant human RSK4 expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	36.0	CHEMBL4924	Homo sapiens	Activity	%	36.0
Active	16565779	CHEMBL3801312	Inhibition of human RSK4 at 300 nM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate preincubated for 20 mins followed by [gamma-33P]-ATP/10 uM ATP addition measured after 120 mins by radiometric assay	B	CN(C)C(=O)Oc1cccc(NC(=O)C2(CN)CCN(c3ncnc4[nH]c5c(c34)CCCC5)CC2)c1		CHEMBL3797874		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
	16614625	CHEMBL3816841	Inhibition of human RSK4 at 1 uM using [KEAKEKRQEQIAKRRRLSLRASTSKSGGSQK] as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	-1.0	CHEMBL4924	Homo sapiens	INH	%	-1.0
	16618651	CHEMBL3816528	Inhibition of full length recombinant human N-terminal GST-tagged RSK4 expressed in baculovirus expression system at 1 uM relative to control	B	CC1(C)OCCn2c1nc1c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL3813842	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	16619697	CHEMBL3820364	Inhibition of recombinant human full length GST-tagged RSK4 expressed in Baculovirus at 1 uM relative to control	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Inhibition	%	75.0	CHEMBL4924	Homo sapiens	INH	%	75.0
Inactive	17937196	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937197	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937198	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937199	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937200	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937201	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937202	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937203	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937204	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937205	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	899.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	899.0
Inactive	17937206	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937207	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937208	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937209	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937210	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937211	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937212	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937213	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	=	Kd	nM	3424.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	3424.0
Inactive	17937214	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937215	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937216	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937217	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937218	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937219	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937220	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937221	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Kd	nM	2181.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	2181.0
Inactive	17937222	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937223	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937224	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	16.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	16.0
Inactive	17937225	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937226	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	=	Kd	nM	1269.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	1269.0
Inactive	17937227	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937228	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937229	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937230	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937231	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937232	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937233	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937234	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937235	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937236	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Kd	nM	419.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	419.0
Inactive	17937237	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937238	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937239	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937240	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937241	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937242	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937243	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937244	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	282.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	282.0
Inactive	17937245	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937246	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937247	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937248	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937249	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937250	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	=	Kd	nM	1981.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	1981.0
Inactive	17937251	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937252	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937253	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937254	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937255	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	981.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	981.0
Inactive	17937256	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937257	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937258	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937259	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937260	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937261	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937262	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937263	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937264	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937265	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	=	Kd	nM	1572.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	1572.0
Inactive	17937266	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937267	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937268	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937269	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937270	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937271	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937272	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937273	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937274	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937275	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937276	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937277	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937278	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937279	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937280	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937281	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937282	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937283	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937284	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937285	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937286	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937287	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937288	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	4.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	4.0
Inactive	17937289	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937290	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937291	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937292	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937293	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937294	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937295	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937296	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937297	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937298	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937299	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937300	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937301	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937302	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937303	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937304	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937305	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937306	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937307	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937308	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937309	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937310	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937311	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937312	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937313	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937314	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937315	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937316	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937317	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937318	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937319	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937320	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937321	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937322	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937323	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937324	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937325	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937326	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937327	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937328	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937329	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937330	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937331	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937332	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937333	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937334	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937335	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937336	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937337	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937338	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937339	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937340	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937341	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937342	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937343	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	=	Kd	nM	23762.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	23762.0
Inactive	17937344	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937345	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937346	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	=	Kd	nM	2688.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	2688.0
Inactive	17937347	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937348	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937349	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937350	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937351	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937352	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937353	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937354	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937355	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937356	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937357	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937358	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937359	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937360	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937361	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937362	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937363	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937364	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937365	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937366	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937367	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937368	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937369	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937370	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937371	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937372	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937373	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937374	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937375	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937376	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937377	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937378	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937379	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937380	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	=	Kd	nM	2376.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	2376.0
Inactive	17937381	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937382	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937383	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937384	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937385	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937386	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937387	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937388	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937389	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937390	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937391	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937392	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937393	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937394	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937395	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937396	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937397	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937398	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937399	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937400	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937401	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937402	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937403	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	=	Kd	nM	276.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	276.0
Inactive	17937404	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937405	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	=	Kd	nM	455.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	455.0
Inactive	17937406	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937407	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937408	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	1513.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	1513.0
Inactive	17937409	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937410	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	=	Kd	nM	5898.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	5898.0
Inactive	17937411	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937412	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937413	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937414	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937415	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937416	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937417	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937418	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937419	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937420	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937421	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937422	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937423	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	=	Kd	nM	141.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	141.0
Inactive	17937424	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937425	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937426	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937427	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937428	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937429	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937430	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937431	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937432	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937433	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937434	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937435	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17937436	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
Active	17937437	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	=	Kd	nM	57.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	57.0
Inactive	17937438	CHEMBL3991876	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4924	Homo sapiens	Kd apparent	nM	30000.0
	18052931	CHEMBL4011943	Inhibition of RSK4 (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	-2.9	CHEMBL4924	Homo sapiens	INH	%	-2.9
	18114848	CHEMBL4025378	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	90.0	CHEMBL4924	Homo sapiens	Activity	%	90.0
	18114849	CHEMBL4025379	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	89.0	CHEMBL4924	Homo sapiens	Activity	%	89.0
	18153033	CHEMBL4034486	Inhibition of RSK4 domain 1 Lysine 2 labelling site (unknown origin) at 10 uM	B	c1cc(-c2c[nH]c3cnccc23)ccn1		CHEMBL4084955	=	Inhibition	%	13.0	CHEMBL4924	Homo sapiens	INH	%	13.0
	18203902	CHEMBL4044189	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in HEK293 cells assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	18203903	CHEMBL4044190	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	94.0	CHEMBL4924	Homo sapiens	Activity	%	94.0
	18225379	CHEMBL4048705	Inhibition of RSK4 (unknown origin) at 1 uM relative to control	B	Nc1cc(Nc2cc(Cl)c3n(c2=O)C2(CCCC2)NC3=O)ncn1		CHEMBL4094975	=	Inhibition	%	58.0	CHEMBL4924	Homo sapiens	INH	%	58.0
	18253245	CHEMBL4054906	Inhibition of human N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	14.0	CHEMBL4924	Homo sapiens	Activity	%	14.0
	18253246	CHEMBL4054906	Inhibition of human N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual activity at 50 nM by KINOMEscan assay relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	46.0	CHEMBL4924	Homo sapiens	Activity	%	46.0
	18253307	CHEMBL4054937	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	50.0	CHEMBL4924	Homo sapiens	Activity	%	50.0
	18253308	CHEMBL4054937	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	96.0	CHEMBL4924	Homo sapiens	Activity	%	96.0
	18265800	CHEMBL4057250	Inhibition of RSK4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	50.7	CHEMBL4924	Homo sapiens	INH	%	50.7
	18265998	CHEMBL4057448	Inhibition of RSK4 (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	-1.3	CHEMBL4924	Homo sapiens	INH	%	-1.3
	18275384	CHEMBL4118518	Inhibition of human RSK4 (1 to 397 residues) expressed in mammalian expression system assessed as enzyme activity at 1 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	34.0	CHEMBL4924	Homo sapiens	Activity	%	34.0
	18276156	CHEMBL4119086	Inhibition of human RSK4 (1 to 397 residues) expressed in mammalian expression system assessed as enzyme activity at 10 uM by KINOMEScan assay relative to control	B	COc1cc(O)c2c(c1)/C=C/C[C@H](O)[C@H](O)C(=O)/C=C\C[C@H](C)OC2=O		CHEMBL1077979	=	Activity	%	3.0	CHEMBL4924	Homo sapiens	Activity	%	3.0
	18282841	CHEMBL4120426	Inhibition of RSK4 (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	50.7	CHEMBL4924	Homo sapiens	INH	%	50.7
	18283061	CHEMBL4120646	Inhibition of RSK4 (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	-2.0	CHEMBL4924	Homo sapiens	INH	%	-2.0
	18283281	CHEMBL4120866	Inhibition of RSK4 (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	13.3	CHEMBL4924	Homo sapiens	INH	%	13.3
	18440444	CHEMBL4157268	Binding affinity to wild-type human partial length N-termianl RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	18440445	CHEMBL4157269	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	81.0	CHEMBL4924	Homo sapiens	Activity	%	81.0
	18484400	CHEMBL4186047	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	76.0	CHEMBL4924	Homo sapiens	Activity	%	76.0
	18484401	CHEMBL4186048	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	18484884	CHEMBL4186047	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in HEK293 cells at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	74.0	CHEMBL4924	Homo sapiens	Activity	%	74.0
	18484885	CHEMBL4186048	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
Active	18499345	CHEMBL4188993	Inhibition of wild-type human partial length RSK4 at 1 uM using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP	B	CNc1ncc2c(-c3ccc(N4CCN(C)CC4)cc3)nn(CC3CCCC3)c2n1		CHEMBL4218175		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
	18507613	CHEMBL4191178	Inhibition of recombinant full-length human Rsk4 at 1 uM using LRRASLGas substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1	Outside typical range	CHEMBL4207014	=	Inhibition	%	-15.0	CHEMBL4924	Homo sapiens	INH	%	-15.0
	18653373	CHEMBL4230219	Inhibition of RSK4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	2.0	CHEMBL4924	Homo sapiens	INH	%	2.0
	18653374	CHEMBL4230219	Inhibition of RSK4 (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	0.0	CHEMBL4924	Homo sapiens	INH	%	0.0
	18655287	CHEMBL4230948	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	18655288	CHEMBL4230947	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	18665530	CHEMBL4233406	Inhibition of RSK4 (unknown origin)	B	O=C(Cc1cccc(OCCCN2CCNCC2)c1)Nc1nc(-c2ccncc2)cs1		CHEMBL4245507	>	IC50	nM	1000.0	CHEMBL4924	Homo sapiens	IC50	nM	1000.0
	18751233	CHEMBL4263942	Inhibition of RSK4 (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	3.0	CHEMBL4924	Homo sapiens	INH	%	3.0
	18752199	CHEMBL4264536	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	94.0	CHEMBL4924	Homo sapiens	Activity	%	94.0
	18752200	CHEMBL4264537	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	99.0	CHEMBL4924	Homo sapiens	Activity	%	99.0
	18858199	CHEMBL4308045	Binding affinity to wild-type human partial length N- terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	94.0	CHEMBL4924	Homo sapiens	Activity	%	94.0
	18858200	CHEMBL4308046	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	18892708	CHEMBL4314541	Inhibition of recombinant full-length human Rsk4 assessed as residual activity at 10 uM using LRRASLG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	Cc1cc(C)c(CNc2nc(Cl)nc3c2ncn3C2CCCC2)c(=O)[nH]1		CHEMBL4557538	=	Activity	%	98.5	CHEMBL4924	Homo sapiens	Activity	%	98.5
	18919534	CHEMBL4322890	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged RPS6KA6 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	21.0	CHEMBL4924	Homo sapiens	Kd	nM	21.0
	18919722	CHEMBL4322890	Binding affinity to recombinant full-length N-terminal His-FLAG-tagged RPS6KA6 (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	14.0	CHEMBL4924	Homo sapiens	Kd	nM	14.0
	18924193	CHEMBL4324183	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	Inhibition	%	29.0	CHEMBL4924	Homo sapiens	INH	%	29.0
	18924206	CHEMBL4324191	Inhibition of RSK4 kinase domain 1 (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748	=	IC50	nM	14000.0	CHEMBL4924	Homo sapiens	IC50	uM	14.0
	18924207	CHEMBL4324191	Inhibition of RSK4 kinase domain 1 (unknown origin) expressed in human HEK293 cells incubated for 2 hrs followed by NanoBRET NanoGlo Substrate addition by NanoBRET assay	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775	>	IC50	nM	20000.0	CHEMBL4924	Homo sapiens	IC50	uM	20.0
	18938287	CHEMBL4327870	Inhibition of human RSK4 assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	98.51	CHEMBL4924	Homo sapiens	Activity	%	98.51
	18938288	CHEMBL4327870	Inhibition of human RSK4 assessed as residual activity at 1 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	96.02	CHEMBL4924	Homo sapiens	Activity	%	96.02
	18938715	CHEMBL4328234	Inhibition of human RSK4 assessed as residual activity at 100 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4924	Homo sapiens	Activity	%	65.0
	18939101	CHEMBL4328598	Inhibition of human RSK4 using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.159	CHEMBL4924	Homo sapiens	IC50	10'-10M	1.59
	18958561	CHEMBL4333630	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	90.0	CHEMBL4924	Homo sapiens	Activity	%	90.0
	18958562	CHEMBL4333629	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	81.0	CHEMBL4924	Homo sapiens	Activity	%	81.0
	18964672	CHEMBL4335277	Inhibition of recombinant full length human Rsk4 assessed as residual activity at 1 uM using LRRASLG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	N=C1NC(=O)/C(=C\c2ccc(-c3cccc([N+](=O)[O-])c3)o2)S1		CHEMBL4455512	=	Activity	%	99.0	CHEMBL4924	Homo sapiens	Activity	%	99.0
	18964673	CHEMBL4335277	Inhibition of recombinant full length human Rsk4 assessed as residual activity at 1 uM using LRRASLG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	C=CCOC(=O)c1cc(-c2ccc(/C=C3/NC(=S)NC3=O)o2)ccc1Cl		CHEMBL4568120	=	Activity	%	92.0	CHEMBL4924	Homo sapiens	Activity	%	92.0
	18972092	CHEMBL4337102	Inhibition of recombinant full length human Rsk4 assessed as residual activity at 10 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	C[C@@H](c1ccccc1)n1nnc2cnc3ccc(-c4cnc5[nH]ccc5c4)cc3c21		CHEMBL4472294	=	Activity	%	62.0	CHEMBL4924	Homo sapiens	Activity	%	62.0
Not Active	19040150	CHEMBL4352051	Inhibition of recombinant full-length human Rsk4 at 10 uM using LRRASLG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	CN1C[C@H](Nc2nc3cc[nH]c3c(=O)n2C)C[C@H](c2ccc3c(c2)OCCO3)C1		CHEMBL4574669		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
Active	19041276	CHEMBL4352537	Inhibition of human RSK4 at 10 uM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
	19059824	CHEMBL4358125	Binding affinity to wild-type human partial length N- terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	77.0	CHEMBL4924	Homo sapiens	Activity	%	77.0
	19059825	CHEMBL4358126	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	96.0	CHEMBL4924	Homo sapiens	Activity	%	96.0
	19090388	CHEMBL4365962	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	58.0	CHEMBL4924	Homo sapiens	Activity	%	58.0
	19090389	CHEMBL4365963	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	100.0	CHEMBL4924	Homo sapiens	Activity	%	100.0
	19092109	CHEMBL4366583	Inhibition of human RSK4 at 100 nM using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1	Outside typical range	CHEMBL4528675	=	Inhibition	%	-20.82	CHEMBL4924	Homo sapiens	INH	%	-20.82
	19144837	CHEMBL4377853	Inhibition of recombinant full-length human Rsk4 at 1 uM using LRRASLG as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting method relative to control	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(NC(=O)CCCCCCCN=C=S)cc3)nc2n1C1CCCC1		CHEMBL4548580	=	Inhibition	%	38.0	CHEMBL4924	Homo sapiens	INH	%	38.0
	19148030	CHEMBL4379426	Inhibition of recombinant full length human Rsk4 using LRRASLG as substrate incubated for 40 mins in presence of [gamma33P]ATP by radiometric scintillation counting analysis	B	CN(C)c1ccc(C(=O)Nc2cccc(NC(=O)COc3ccc4c(=O)ccoc4c3)c2)cc1		CHEMBL4438748	>	IC50	nM	10000.0	CHEMBL4924	Homo sapiens	IC50	uM	10.0
	19153145	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1		CHEMBL4549459	=	IC50	nM	8910.0	CHEMBL4924	Homo sapiens	IC50	nM	8910.0
	19153146	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	Cc1noc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1		CHEMBL4553949	=	IC50	nM	2360.0	CHEMBL4924	Homo sapiens	IC50	nM	2360.0
Not Determined	19153147	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	O=C(CC(F)(F)F)N1CCN(Cc2ccnc(Nc3nc4ccc(-c5nc(C6CC6)no5)cc4[nH]3)c2)CC1		CHEMBL4466150		IC50			CHEMBL4924	Homo sapiens	IC50		
Not Determined	19153148	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CC(C)Cc1noc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)n1		CHEMBL4547610		IC50			CHEMBL4924	Homo sapiens	IC50		
	19153149	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	Cn1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)cn1		CHEMBL4436416	=	IC50	nM	11200.0	CHEMBL4924	Homo sapiens	IC50	nM	11200.0
	19153150	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CCn1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)cn1		CHEMBL4453481	=	IC50	nM	8850.0	CHEMBL4924	Homo sapiens	IC50	nM	8850.0
	19153151	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	O=C(CC(F)(F)F)N1CCN(Cc2ccnc(Nc3nc4ccc(-c5cnn(CC6CC6)c5)cc4[nH]3)c2)CC1		CHEMBL4468020	=	IC50	nM	4120.0	CHEMBL4924	Homo sapiens	IC50	nM	4120.0
	19153152	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cnn(CC5CC5)c4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4435393	=	IC50	nM	3220.0	CHEMBL4924	Homo sapiens	IC50	nM	3220.0
	19153153	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cnn(CC5CCC5)c4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4436188	=	IC50	nM	325.0	CHEMBL4924	Homo sapiens	IC50	nM	325.0
	19153154	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	Cc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ccn1		CHEMBL4515413	=	IC50	nM	1060.0	CHEMBL4924	Homo sapiens	IC50	nM	1060.0
	19153155	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CN(C)c1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ccn1		CHEMBL4451595	=	IC50	nM	2830.0	CHEMBL4924	Homo sapiens	IC50	nM	2830.0
	19153156	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	Cc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1		CHEMBL4552254	=	IC50	nM	434.0	CHEMBL4924	Homo sapiens	IC50	nM	434.0
	19153157	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	Cc1cc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1		CHEMBL4538751	=	IC50	nM	170.0	CHEMBL4924	Homo sapiens	IC50	nM	170.0
	19153158	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	COCc1cc(-c2ccc3nc(Nc4cc([C@@H](C)N5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1		CHEMBL4566796	=	IC50	nM	192.0	CHEMBL4924	Homo sapiens	IC50	nM	192.0
	19153159	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(OCC5CC5)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4454902	=	IC50	nM	1260.0	CHEMBL4924	Homo sapiens	IC50	nM	1260.0
	19153160	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CNc1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1		CHEMBL4594167	=	IC50	nM	177.0	CHEMBL4924	Homo sapiens	IC50	nM	177.0
	19153161	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CN(C)c1cc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)ncn1		CHEMBL4453292	=	IC50	nM	528.0	CHEMBL4924	Homo sapiens	IC50	nM	528.0
	19153162	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673	=	IC50	nM	276.0	CHEMBL4924	Homo sapiens	IC50	nM	276.0
	19153163	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CC(C)Oc1cncnc1-c1ccc2nc(Nc3cc([C@@H](C)N4CCN(C(=O)CC(F)(F)F)CC4)ccn3)[nH]c2c1		CHEMBL4543618	=	IC50	nM	7.0	CHEMBL4924	Homo sapiens	IC50	nM	7.0
	19153164	CHEMBL4380525	Inhibition of recombinant full length human His6-tagged RSK4 expressed in baculovirus infected sf21 cells using biotin labelled Ahx-KKLNRTLSFAEPG peptide as substrate preincubated with enzyme for 15 mins followed by substrate addition and further incubated for 30 mins in presence of 10 uM of ATP by TR-FRET assay	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591	=	IC50	nM	6110.0	CHEMBL4924	Homo sapiens	IC50	nM	6110.0
	19159652	CHEMBL4382756	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	15.0	CHEMBL4924	Homo sapiens	Activity	%	15.0
	19159653	CHEMBL4382757	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	15.0	CHEMBL4924	Homo sapiens	Activity	%	15.0
	19191354	CHEMBL4389476	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	19191355	CHEMBL4389475	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	34.0	CHEMBL4924	Homo sapiens	INH	%	34.0
	19192138	CHEMBL4389952	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	89.0	CHEMBL4924	Homo sapiens	INH	%	89.0
	19192139	CHEMBL4389953	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	88.0	CHEMBL4924	Homo sapiens	INH	%	88.0
	19200394	CHEMBL4391578	Binding affinity to wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	2.2	CHEMBL4924	Homo sapiens	Activity	%	2.2
	19200395	CHEMBL4391579	Binding affinity to wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	57.0	CHEMBL4924	Homo sapiens	Activity	%	57.0
	19266607	CHEMBL4405557	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	19266608	CHEMBL4405558	Inhibition of wild-type human partial length C-terminal RSK4 kinase domain 2 (I401 to Y711 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4924	Homo sapiens	INH	%	50.0
	19276122	CHEMBL4408125	Inhibition of recombinant human full length RSK4 at 1 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	22.0	CHEMBL4924	Homo sapiens	INH	%	22.0
	20600666	CHEMBL4603618	Inhibition of recombinant full length human N-terminal GST-tagged RPS6KA6 expressed in baculovirus expression system using ser/Thr20 peptide as substrate incubated for 60 mins in presence of ATP by Z'-LYTE assay	B	C[C@@H]1C[C@H]1C(=O)N1CCN(c2cnc(C#N)c(-c3cnn(C)c3)n2)C[C@H]1C		CHEMBL4634634	>	IC50	nM	100000.0	CHEMBL4924	Homo sapiens	IC50	uM	100.0
	20680694	CHEMBL4623002	Inhibition of RSK4 (unknown origin) using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK a substrate by [32P] gammaATP assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	15.0	CHEMBL4924	Homo sapiens	IC50	nM	15.0
	22423259	CHEMBL4674205	Inhibition of human RSK4 using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	98.58	CHEMBL4924	Homo sapiens	Activity	%	98.58
	22423260	CHEMBL4674205	Inhibition of human RSK4 using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	41.58	CHEMBL4924	Homo sapiens	Activity	%	41.58
	22770397	CHEMBL4704294	Inhibition of RSK4 (unknown origin) at 1 uM relative to control	B	Cc1cn([C@@H](C)[C@]2(F)CCNC2)c2nc(C(N)=O)cc(Cl)c12		CHEMBL4778578	=	Inhibition	%	53.0	CHEMBL4924	Homo sapiens	INH	%	53.0
	22843245	CHEMBL4720259	Inhibition of RSK4 (unknown origin)	B	C=CC(=O)N1CCC(Cn2cc(-c3ccc4c(c3)OCO4)c3c(N)ncnc32)CC1		CHEMBL4755698	>	IC50	nM	10000.0	CHEMBL4924	Homo sapiens	IC50	nM	10000.0
	22843575	CHEMBL4720561	Inhibition of human RSK4 using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	0.134	CHEMBL4924	Homo sapiens	IC50	10^-10M	1.34
	22843918	CHEMBL4720904	Inhibition of human RSK4 assessed as residual activity using KEAKEKRQEQIAKRRRLSSLRASTSKSGGSQK as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	102.59	CHEMBL4924	Homo sapiens	Activity	%	102.59
	22844860	CHEMBL4721535	Inhibition of wild-type human partial length N-terminal RSK4 kinase domain 1 (M1 to E397 residues) expressed in mammalian expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	87.46	CHEMBL4924	Homo sapiens	Activity	%	87.46
	22883480	CHEMBL4727565	Inhibition of recombinant human full-length GST-tagged RSK4 expressed in baculovirus expression system	B	CC(C)n1cnnc1-c1cccc(NC(=O)[C@H]2CN(c3ccc(C4CC4)nc3)CCO2)n1		CHEMBL4744428	<=	IC50	nM	500.0	CHEMBL4924	Homo sapiens	IC50	nM	500.0
	22944001	CHEMBL4742521	Inhibition of RSK4 c-terminal kinase domain (unknown origin) assessed as residual ligand binding level at 10000 nM relative to control	B	COCc1cc(C)nc2sc(C(N)=O)c(N)c12		CHEMBL4780986	=	Activity	%	72.0	CHEMBL4924	Homo sapiens	Activity	%	72.0
	22952991	CHEMBL4766928	Inhibition of recombinant full length human Rsk4 assessed as residual activity at 10 uM using LRRASLG as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting based radiometry assay relative to control	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Nc3ncnc4c3OCCCN4)cc2)no1		CHEMBL4793380	=	Activity	%	19.0	CHEMBL4924	Homo sapiens	Activity	%	19.0
	23122809	CHEMBL4805160	Inhibition of human N-terminal RSK4 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	60.0	CHEMBL4924	Homo sapiens	Activity	%	60.0
	23122810	CHEMBL4805161	Inhibition of human C-terminal RSK4 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	96.0	CHEMBL4924	Homo sapiens	Activity	%	96.0
	23123504	CHEMBL4805748	Inhibition of human N-terminal RSK4 kinase domain 1 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	92.0	CHEMBL4924	Homo sapiens	Activity	%	92.0
	23123505	CHEMBL4805749	Inhibition of human C-terminal RSK4 kinase domain 2 assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	82.0	CHEMBL4924	Homo sapiens	Activity	%	82.0
	23123958	CHEMBL4806202	Inhibition of DNA-tagged human N-terminal RSK4 kinase domain 1 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	99.0	CHEMBL4924	Homo sapiens	Activity	%	99.0
	23123959	CHEMBL4806203	Inhibition of DNA-tagged human C-terminal RSK4 kinase domain 2 assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	71.0	CHEMBL4924	Homo sapiens	Activity	%	71.0
	23125098	CHEMBL4806765	Inhibition of human N-terminal RSK4 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	78.0	CHEMBL4924	Homo sapiens	Activity	%	78.0
	23125099	CHEMBL4806765	Inhibition of human N-terminal RSK4 kinase domain 1 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	80.0	CHEMBL4924	Homo sapiens	Activity	%	80.0
	23125100	CHEMBL4806766	Inhibition of human C-terminal RSK4 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	94.0	CHEMBL4924	Homo sapiens	Activity	%	94.0
	23125101	CHEMBL4806766	Inhibition of human C-terminal RSK4 kinase domain 2 assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	79.0	CHEMBL4924	Homo sapiens	Activity	%	79.0
	23127475	CHEMBL4807626	Inhibition of RPS6KA6 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	49.0	CHEMBL4924	Homo sapiens	Activity	%	49.0
	23127476	CHEMBL4807626	Inhibition of RPS6KA6 (unknown origin) assessed as residual activity at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Activity	%	95.0	CHEMBL4924	Homo sapiens	Activity	%	95.0
	23128557	CHEMBL4807994	Inhibition of RPS6KA6 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	=	Activity	%	25.0	CHEMBL4924	Homo sapiens	Activity	%	25.0
	23128558	CHEMBL4807994	Inhibition of RPS6KA6 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	>	Activity	%	75.0	CHEMBL4924	Homo sapiens	Activity	%	75.0
	23128559	CHEMBL4807994	Inhibition of RPS6KA6 (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Activity	%	75.0	CHEMBL4924	Homo sapiens	Activity	%	75.0
	23213444	CHEMBL4822978	Inhibition of human recombinant RSK4 in presence of ATP by Z-lyte kinase assay	B	OC1(c2ccccc2)CSC(=S)N1Cc1ccncc1		CHEMBL4861930	=	Inhibition	%	18.0	CHEMBL4924	Homo sapiens	INH	%	18.0
	23297879	CHEMBL4841337	Inhibition of RSK4 (unknown origin)	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	15.0	CHEMBL4924	Homo sapiens	IC50	nM	15.0
	23297887	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	C=CC(=O)Nc1cccc(N2C(=O)OC(C)(C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL4869608	=	IC50	nM	117.0	CHEMBL4924	Homo sapiens	IC50	nM	117.0
	23297888	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	C=CC(=O)Nc1cccc(N2C(=O)OC(C(C)C)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL4865220	=	IC50	nM	2118.0	CHEMBL4924	Homo sapiens	IC50	nM	2118.0
	23297889	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	C=CC(=O)Nc1cccc(N2C(=O)OC(CCC)c3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL4848180	=	IC50	nM	10567.0	CHEMBL4924	Homo sapiens	IC50	nM	10567.0
	23297890	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)CCN1c2nc(Nc3cc(F)c(O)c(F)c3)ncc2N(C)C(=O)C1C		CHEMBL573107	=	IC50	nM	11.5	CHEMBL4924	Homo sapiens	IC50	nM	11.5
	23297891	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)CCN1C(=O)OC(C(C)C)c2cnc(Nc3cc(F)c(O)c(F)c3)nc21		CHEMBL4870807	=	IC50	nM	15.5	CHEMBL4924	Homo sapiens	IC50	nM	15.5
	23297892	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CNC(=O)c1cccc(N2C(=O)OC(C(C)C)c3cnc(Nc4cc(F)c(O)c(F)c4)nc32)c1		CHEMBL4850184	=	IC50	nM	395.0	CHEMBL4924	Homo sapiens	IC50	nM	395.0
	23297893	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)CCN1C(=O)OC(C(C)C)c2cnc(Nc3ccc(O)cc3)nc21		CHEMBL4856762	=	IC50	nM	84.0	CHEMBL4924	Homo sapiens	IC50	nM	84.0
	23297894	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4866663	=	IC50	nM	4725.0	CHEMBL4924	Homo sapiens	IC50	nM	4725.0
	23297895	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4845942	=	IC50	nM	25.0	CHEMBL4924	Homo sapiens	IC50	nM	25.0
	23297896	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762	=	IC50	nM	9.5	CHEMBL4924	Homo sapiens	IC50	nM	9.5
	23297897	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847469	=	IC50	nM	12.0	CHEMBL4924	Homo sapiens	IC50	nM	12.0
	23297898	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC1CCCC(N2C(=O)OC(C(C)C)c3cnc(Nc4cc(F)c(O)c(F)c4)nc32)C1		CHEMBL4870231	=	IC50	nM	15.0	CHEMBL4924	Homo sapiens	IC50	nM	15.0
	23297899	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC1CCC(N2C(=O)OC(C(C)C)c3cnc(Nc4cc(F)c(O)c(F)c4)nc32)CC1		CHEMBL4872665	=	IC50	nM	28.5	CHEMBL4924	Homo sapiens	IC50	nM	28.5
	23297900	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCOC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4850890	=	IC50	nM	54.9	CHEMBL4924	Homo sapiens	IC50	nM	54.9
	23297901	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	COc1c(F)cc(Nc2ncc3c(n2)N(CCC(C)C)C(=O)OC3C(C)C)cc1F		CHEMBL4854622	=	IC50	nM	13781.0	CHEMBL4924	Homo sapiens	IC50	nM	13781.0
	23297902	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3ccc(N4CCN(C)CC4)cc3)ncc21		CHEMBL4852557	=	IC50	nM	300.5	CHEMBL4924	Homo sapiens	IC50	nM	300.5
	23297903	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3ccc(N4CCNCC4)cc3)ncc21		CHEMBL4874868	=	IC50	nM	410.0	CHEMBL4924	Homo sapiens	IC50	nM	410.0
	23297904	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3ccc(O)c(F)c3)ncc21		CHEMBL4846978	=	IC50	nM	18.0	CHEMBL4924	Homo sapiens	IC50	nM	18.0
	23297905	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)cc(F)c3)ncc21		CHEMBL4871187	=	IC50	nM	9735.0	CHEMBL4924	Homo sapiens	IC50	nM	9735.0
	23297906	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(Cl)c(O)c(Cl)c3)ncc21		CHEMBL4846647	=	IC50	nM	3588.0	CHEMBL4924	Homo sapiens	IC50	nM	3588.0
	23297907	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3ccc(O)c(Cl)c3)ncc21		CHEMBL4852908	=	IC50	nM	33.0	CHEMBL4924	Homo sapiens	IC50	nM	33.0
	23297908	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(F)c(F)c3)ncc21		CHEMBL4868071	=	IC50	nM	7343.5	CHEMBL4924	Homo sapiens	IC50	nM	7343.5
	23297909	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(C(F)(F)F)c(F)c3)ncc21		CHEMBL4849875	=	IC50	nM	17627.0	CHEMBL4924	Homo sapiens	IC50	nM	17627.0
	23297910	CHEMBL4841342	Inhibition of RSK4 (unknown origin) incubated for 40 mins in presence of ATP and lipid substrate by Kinase-Glo plus luminescence assay	B	CCC(CC)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4846725	=	IC50	nM	12.0	CHEMBL4924	Homo sapiens	IC50	nM	12.0
Dose-Dependent Effect	23297911	CHEMBL4841343	Inhibition of RSK4 in human TE-10 cells assessed as suppression of RPS6 phosphorylation measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
Dose-Dependent Effect	23297912	CHEMBL4841344	Inhibition of RSK4 in human TE-10 cells assessed as suppression of GSK3beta phosphorylation measured after 24 hrs by Western blot analysis	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762		Inhibition	%		CHEMBL4924	Homo sapiens	INH		
	23297913	CHEMBL4841345	Inhibition of RSK4 in human TE-10 cells assessed as suppression of RPS6 phosphorylation at 10 uM measured after 24 hrs by Western blot analysis relative to control	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762	=	Inhibition	%	100.0	CHEMBL4924	Homo sapiens	INH	%	100.0
	23297914	CHEMBL4841346	Inhibition of RSK4 in human TE-10 cells assessed as suppression of GSK3beta phosphorylation at 10 uM measured after 24 hrs by Western blot analysis relative to control	B	CC(C)C1OC(=O)N(C2CCCC2)c2nc(Nc3cc(F)c(O)c(F)c3)ncc21		CHEMBL4847762	=	Inhibition	%	100.0	CHEMBL4924	Homo sapiens	INH	%	100.0
Not Active	23317645	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23317646	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	94.0	CHEMBL4924	Homo sapiens	% Control	%	94.0
Not Active	23318113	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23318114	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	98.0	CHEMBL4924	Homo sapiens	% Control	%	98.0
Not Active	23318779	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23318780	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	93.0	CHEMBL4924	Homo sapiens	% Control	%	93.0
Not Active	23319263	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	94.0	CHEMBL4924	Homo sapiens	% Control	%	94.0
Not Active	23319264	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23319900	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	76.4	CHEMBL4924	Homo sapiens	% Control	%	76.4
Not Active	23319901	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23320375	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	96.6	CHEMBL4924	Homo sapiens	% Control	%	96.6
Not Active	23320376	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	79.2	CHEMBL4924	Homo sapiens	% Control	%	79.2
Not Active	23321053	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23321054	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23321521	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23321522	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	94.0	CHEMBL4924	Homo sapiens	% Control	%	94.0
Not Active	23322151	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	78.0	CHEMBL4924	Homo sapiens	% Control	%	78.0
Not Active	23322152	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	77.0	CHEMBL4924	Homo sapiens	% Control	%	77.0
Not Active	23322619	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23322620	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	76.0	CHEMBL4924	Homo sapiens	% Control	%	76.0
Not Active	23323308	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23323309	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23323776	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	87.0	CHEMBL4924	Homo sapiens	% Control	%	87.0
Not Active	23323777	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23324129	CHEMBL4880747	Rsk4 (h) Millipore kinase activity assay	B	CC1=C(C#N)C(c2ccc3[nH]nc(C)c3c2)C(C#N)=C(C)N1		CHEMBL4593677		Inhibition	%	52.0	CHEMBL4924	Homo sapiens	% inhibition	%	52.0
Not Active	23324630	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23324631	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	77.4	CHEMBL4924	Homo sapiens	% Control	%	77.4
Not Active	23325265	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	86.0	CHEMBL4924	Homo sapiens	% Control	%	86.0
Not Active	23325266	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	97.0	CHEMBL4924	Homo sapiens	% Control	%	97.0
Not Active	23325733	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23325734	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23326380	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23326381	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	59.0	CHEMBL4924	Homo sapiens	% Control	%	59.0
Not Active	23326848	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23326849	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	96.0	CHEMBL4924	Homo sapiens	% Control	%	96.0
Not Active	23327548	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	78.0	CHEMBL4924	Homo sapiens	% Control	%	78.0
Not Active	23327549	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	87.0	CHEMBL4924	Homo sapiens	% Control	%	87.0
Not Active	23328016	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23328017	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23328603	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	78.0	CHEMBL4924	Homo sapiens	% Control	%	78.0
Not Active	23328604	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	66.0	CHEMBL4924	Homo sapiens	% Control	%	66.0
Not Active	23329071	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23329072	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23329518	CHEMBL4881225	Rsk4(h) Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	103.0	CHEMBL4924	Homo sapiens	% residual kinase activity	%	103.0
Not Active	23330017	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23330018	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23330485	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23330486	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23331241	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	76.0	CHEMBL4924	Homo sapiens	% Control	%	76.0
Not Active	23331242	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23331709	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	98.0	CHEMBL4924	Homo sapiens	% Control	%	98.0
Not Active	23331710	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23332296	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	80.4	CHEMBL4924	Homo sapiens	% Control	%	80.4
Not Active	23332297	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	74.9	CHEMBL4924	Homo sapiens	% Control	%	74.9
Not Active	23332762	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23332763	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23333480	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23333481	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	87.7	CHEMBL4924	Homo sapiens	% Control	%	87.7
Not Active	23334119	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	85.0	CHEMBL4924	Homo sapiens	% Control	%	85.0
Not Active	23334120	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23334587	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23334588	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23335566	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	95.0	CHEMBL4924	Homo sapiens	% Control	%	95.0
Not Active	23335567	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	99.0	CHEMBL4924	Homo sapiens	% Control	%	99.0
Not Active	23336034	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	72.0	CHEMBL4924	Homo sapiens	% Control	%	72.0
Not Active	23336035	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23336661	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	67.0	CHEMBL4924	Homo sapiens	% Control	%	67.0
Not Active	23336662	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	86.0	CHEMBL4924	Homo sapiens	% Control	%	86.0
Not Active	23337129	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23337130	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	95.0	CHEMBL4924	Homo sapiens	% Control	%	95.0
Not Active	23337767	CHEMBL4882138	RPS6KA6 Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	105.0	CHEMBL4924	Homo sapiens	% Ctrl	%	105.0
Not Active	23338210	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	96.0	CHEMBL4924	Homo sapiens	% Control	%	96.0
Not Active	23338211	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23338678	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	83.0	CHEMBL4924	Homo sapiens	% Control	%	83.0
Not Active	23338679	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23339290	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23339291	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23339758	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Active	23339759	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	0.0	CHEMBL4924	Homo sapiens	% Control	%	0.0
Not Active	23340395	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	97.0	CHEMBL4924	Homo sapiens	% Control	%	97.0
Not Active	23340396	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	64.0	CHEMBL4924	Homo sapiens	% Control	%	64.0
Not Active	23340863	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	99.0	CHEMBL4924	Homo sapiens	% Control	%	99.0
Not Active	23340864	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23341520	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	96.0	CHEMBL4924	Homo sapiens	% Control	%	96.0
Not Active	23341521	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23341988	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	94.0	CHEMBL4924	Homo sapiens	% Control	%	94.0
Not Active	23341989	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	98.0	CHEMBL4924	Homo sapiens	% Control	%	98.0
Not Active	23342604	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23342605	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	92.0	CHEMBL4924	Homo sapiens	% Control	%	92.0
Not Active	23343072	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23343073	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23343702	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	95.0	CHEMBL4924	Homo sapiens	% Control	%	95.0
Not Active	23343703	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	93.0	CHEMBL4924	Homo sapiens	% Control	%	93.0
Not Active	23344170	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	86.0	CHEMBL4924	Homo sapiens	% Control	%	86.0
Not Active	23344171	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	85.0	CHEMBL4924	Homo sapiens	% Control	%	85.0
Not Active	23344808	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23344809	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23345381	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	92.0	CHEMBL4924	Homo sapiens	% Control	%	92.0
Not Active	23345382	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23345849	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	60.0	CHEMBL4924	Homo sapiens	% Control	%	60.0
Not Active	23345850	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	86.0	CHEMBL4924	Homo sapiens	% Control	%	86.0
Not Active	23346426	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23346427	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	77.2	CHEMBL4924	Homo sapiens	% Control	%	77.2
Not Active	23346894	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	90.8	CHEMBL4924	Homo sapiens	% Control	%	90.8
Not Active	23346895	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23347494	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	83.4	CHEMBL4924	Homo sapiens	% Control	%	83.4
Not Active	23347495	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	96.8	CHEMBL4924	Homo sapiens	% Control	%	96.8
Not Active	23347986	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23347987	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	82.7	CHEMBL4924	Homo sapiens	% Control	%	82.7
Not Active	23348565	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	88.0	CHEMBL4924	Homo sapiens	% Control	%	88.0
Not Active	23348566	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23349033	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	76.0	CHEMBL4924	Homo sapiens	% Control	%	76.0
Not Active	23349034	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	90.0	CHEMBL4924	Homo sapiens	% Control	%	90.0
Not Active	23349620	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	83.0	CHEMBL4924	Homo sapiens	% Control	%	83.0
Not Active	23349621	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	90.0	CHEMBL4924	Homo sapiens	% Control	%	90.0
Not Active	23350238	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23350239	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23350706	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23350707	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23351311	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23351312	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23351779	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	71.0	CHEMBL4924	Homo sapiens	% Control	%	71.0
Not Active	23351780	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23352219	CHEMBL4882908	RPS6KA6 (RSK4) Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	3.232	CHEMBL4924	Homo sapiens	% Inhibition	%	3.2322
Not Active	23352803	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	77.0	CHEMBL4924	Homo sapiens	% Control	%	77.0
Not Active	23352804	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	85.0	CHEMBL4924	Homo sapiens	% Control	%	85.0
Not Active	23353271	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	78.0	CHEMBL4924	Homo sapiens	% Control	%	78.0
Not Active	23353272	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	79.0	CHEMBL4924	Homo sapiens	% Control	%	79.0
Not Active	23354153	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23354154	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23354621	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23354622	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23355353	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23355354	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23355821	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23355822	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23356457	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23356458	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23356925	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23356926	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23357534	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23357535	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23358181	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23358182	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23358649	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	80.0	CHEMBL4924	Homo sapiens	% Control	%	80.0
Not Active	23358650	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	89.0	CHEMBL4924	Homo sapiens	% Control	%	89.0
Not Active	23359235	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	63.5	CHEMBL4924	Homo sapiens	% Control	%	63.5
Not Active	23359236	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23359833	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23359834	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23360301	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23360302	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23360886	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	85.0	CHEMBL4924	Homo sapiens	% Control	%	85.0
Not Active	23360887	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23361354	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	86.0	CHEMBL4924	Homo sapiens	% Control	%	86.0
Not Active	23361355	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23361927	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	51.0	CHEMBL4924	Homo sapiens	% Control	%	51.0
Not Active	23361928	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23362463	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	89.0	CHEMBL4924	Homo sapiens	% Control	%	89.0
Not Active	23362464	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23362931	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23362932	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23364573	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	67.0	CHEMBL4924	Homo sapiens	% Control	%	67.0
Not Active	23364574	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23365041	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23365042	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23365780	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	90.0	CHEMBL4924	Homo sapiens	% Control	%	90.0
Not Active	23365781	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	97.0	CHEMBL4924	Homo sapiens	% Control	%	97.0
Not Active	23366323	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	93.0	CHEMBL4924	Homo sapiens	% Control	%	93.0
Not Active	23366324	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23366507	CHEMBL4883800	NanoBRET (RPS6KA6)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1	Non standard unit for type	CHEMBL4436748		IC50	µM	14.0	CHEMBL4924	Homo sapiens	IC50	µM	14.0
Not Active	23366515	CHEMBL4883800	NanoBRET (RPS6KA6)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1	Non standard unit for type	CHEMBL4531775	>	IC50	µM	20.0	CHEMBL4924	Homo sapiens	IC50	µM	20.0
Not Active	23366913	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23366914	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	61.0	CHEMBL4924	Homo sapiens	% Control	%	61.0
Not Active	23367381	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23367382	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	92.0	CHEMBL4924	Homo sapiens	% Control	%	92.0
Not Active	23367738	CHEMBL4884091	RPS6KA6 ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	85.0	CHEMBL4924	Homo sapiens	% Residual activity with Skepinone-L	%	85.0
Not Active	23368259	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23368260	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23368727	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23368728	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	95.0	CHEMBL4924	Homo sapiens	% Control	%	95.0
Not Active	23369326	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	97.0	CHEMBL4924	Homo sapiens	% Control	%	97.0
Not Active	23369327	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	56.0	CHEMBL4924	Homo sapiens	% Control	%	56.0
Not Active	23369794	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23369795	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23370235	CHEMBL4884474	Rsk4(h) Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	2.0	CHEMBL4924	Homo sapiens	% residual kinase activity	%	2.0
Active	23370762	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	2.9	CHEMBL4924	Homo sapiens	% Control	%	2.9
Not Active	23370763	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23371230	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23371231	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	83.0	CHEMBL4924	Homo sapiens	% Control	%	83.0
Not Active	23372039	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	97.0	CHEMBL4924	Homo sapiens	% Control	%	97.0
Not Active	23372040	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23372507	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23372508	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
	23372886	CHEMBL4884851	RSK4(R6A6LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4924	Homo sapiens	pIC50		6.0
	23373295	CHEMBL4885142	RSK4(R6A6LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4924	Homo sapiens	pIC50		6.0
	23373651	CHEMBL4885428	RSK4(R6A6LGF1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4924	Homo sapiens	pIC50		6.0
Not Active	23375374	CHEMBL4886356	ribosomal protein S6 kinase, 90kDa, polypeptide 6  Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	-10.0	CHEMBL4924	Homo sapiens	% inhibition	%	-10.0
Not Active	23375934	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	77.0	CHEMBL4924	Homo sapiens	% Control	%	77.0
Not Active	23375935	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23376402	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23376403	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23376979	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	95.0	CHEMBL4924	Homo sapiens	% Control	%	95.0
Not Active	23376980	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	92.0	CHEMBL4924	Homo sapiens	% Control	%	92.0
Not Active	23377447	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	96.0	CHEMBL4924	Homo sapiens	% Control	%	96.0
Not Active	23377448	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23378307	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	81.0	CHEMBL4924	Homo sapiens	% Control	%	81.0
Not Active	23378308	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23378775	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	82.0	CHEMBL4924	Homo sapiens	% Control	%	82.0
Not Active	23378776	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23379942	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	84.0	CHEMBL4924	Homo sapiens	% Control	%	84.0
Not Active	23379943	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	97.0	CHEMBL4924	Homo sapiens	% Control	%	97.0
Not Active	23380410	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	89.0	CHEMBL4924	Homo sapiens	% Control	%	89.0
Not Active	23380411	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23381104	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	77.0	CHEMBL4924	Homo sapiens	% Control	%	77.0
Not Active	23381105	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	78.0	CHEMBL4924	Homo sapiens	% Control	%	78.0
Not Active	23381752	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23381753	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23382220	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23382221	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23382844	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	70.0	CHEMBL4924	Homo sapiens	% Control	%	70.0
Slightly Active	23382845	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	49.0	CHEMBL4924	Homo sapiens	% Control	%	49.0
Active	23383312	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	4.6	CHEMBL4924	Homo sapiens	% Control	%	4.6
Not Active	23383313	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	79.0	CHEMBL4924	Homo sapiens	% Control	%	79.0
Not Active	23383981	CHEMBL4887584	RPS6KA6 Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	98.0	CHEMBL4924	Homo sapiens	% Ctrl	%	98.0
Not Active	23384455	CHEMBL4888050	Rsk4(h) Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	-6.19	CHEMBL4924	Homo sapiens	% inhibition	%	-6.19
Not Active	23384713	CHEMBL4888239	RPS6KA6 (RSK4) SelectScreen Kinase panel (LifeTechnologies)	B	C=CC(=O)Nc1ccc2[nH]c(=O)n(C3CCN(Cc4ccc(-c5nc6cc[nH]c(=O)c6cc5-c5ccccc5)cc4)CC3)c2c1		CHEMBL4795065		Inhibition	%	14.0	CHEMBL4924	Homo sapiens	% Inhibition	%	14.0
Not Active	23385227	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23385228	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	91.0	CHEMBL4924	Homo sapiens	% Control	%	91.0
Not Active	23385694	CHEMBL4879951	KinomeScan assay: inhibition of RSK4(Kin.Dom.1-N-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	100.0	CHEMBL4924	Homo sapiens	% Control	%	100.0
Not Active	23385695	CHEMBL4879952	KinomeScan assay: inhibition of RSK4(Kin.Dom.2-C-terminal)	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	98.0	CHEMBL4924	Homo sapiens	% Control	%	98.0
